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ABSTRACT
Neutrophils are the most abundant leukocytes (50% to 70%) in humans and are the first
immune cell population recruited to the sites of infection. They are known to act as the first line
of innate immune defense against invading pathogens, and more recently, to playing a crucial
role in orchestrating adaptive immune responses. The role of neutrophils in the respiratory viral
infections till date remains unclear and controversial. Previous studies demonstrated both
beneficial as well as pathogenic role for neutrophils in respiratory viral infections, especially
influenza.
Previous findings reported an early and high influx of neutrophils into the airways early
after respiratory pneumovirus infection. Nevertheless, the role of these cells in respiratory
pneumovirus induced host responses remains largely unclear. Human metapneumovirus
(HMPV) and Human respiratory syncytial virus (HRSV) belong to the family Pneumoviridae,
which are significant human respiratory pathogens and causing acute lower respiratory tract
infection with similar clinical symptoms in the young, elderly and immune-compromised
individuals.
In understanding the role of neutrophils in these infections, we used in vivo mouse
models of HMPV or HRSV infection. Depletion of neutrophils during HMPV infection in mice
led to increased inflammatory responses and disease outcome, proving the beneficial role of
these cells during HMPV infection. On the other hand, RSV infection in neonatal mice exposed
to cigarette smoke in-utero exhibited exacerbated lung pathology characterized by an increased
neutrophil recruitment into the airways, suggesting a harmful role of neutrophils when recruited
in excessive levels. Overall, our studies indicate that neutrophil play a key role in orchestrating
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host inflammatory responses during respiratory pneumovirus infection and that, a fine balance in
the recruitment of neutrophils is essential during respiratory viral infection.
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CHAPTER 1
INTRODUCTION
1.1. Introduction
Human metapneumovirus (HMPV), belongs to the Paramyxoviridae family and
represents the first human member of the genus Metapneumovirus. HMPV is a leading
respiratory viral pathogen causing acute respiratory tract infection (ARTI) in young children, the
elderly and immunocompromised individuals [1]. HMPV was first isolated in the Netherlands in
2001 from respiratory specimens of young children suffering with acute respiratory tract illness
[2] and represents a major respiratory pathogen worldwide. Epidemiological studies show that
HMPV is responsible for 5%–15% of pediatric hospitalizations for respiratory tract infections
[3,4,5,6,7]. It induces clinical syndromes ranging from mild disease to more severe disease, with
high fever, wheezing, severe cough, difficulty in breathing, tachypnea, bronchiolitis and
pneumonia [8,9,10].
hHMPV is an enveloped, negative sense single-stranded RNA virus (Figure 1.1). Based
on phylogenetic analysis, HMPV is classified into four genetic lineages, named A1, A2, B1 and
B2 that divide into the A and B antigenic subgroups that belong to one serotype [11, 12]. HMPV
genome size is approximately 13,000 nt as it varies depending on the strain. Examples of the
subgroup A indicate that the strain CAN97-83 is 13,335 nt and NL/00/1 is 13,350 nt, and for the
subgroup B: CAN98-75 is 13,280 nt and NL/1/99 is 13,293 nt [11,13]. The HMPV sequence
includes eight genes encoding nine proteins: nucleocapsid (N), phosphoprotein (P), matrix (M),
second matrix (M2-1, M2-2), fusion (F), small hydrophobic (SH), attachment (G) and*

This chapter has been published as: Cheemarla NR. and A. Guerrero-Plata. Immune Response to
Human Metapneumovirus Infection: What We Have Learned from the Mouse Model.
Pathogens, 2015, 4, 682-696.
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RNA-dependent RNA polymerase (L). The gene order in HMPV is represented as 3′-N-P-M-FM2- SH-G-L-5′ (Figure 1.1). The attachment (G) and small hydrophobic (SH) genes are found to
be highly variable while a high level of sequence conservation has been observed for the fusion
(F) gene [13]. The G protein is a transmembrane surface glycoprotein, which initiates the virushost cell membrane attachment and so considered as a key player in viral replication. The fusion
(F) protein is required for the fusion of virus with host cell membrane and is capable of being
accessed by neutralizing antibodies. The nucleocapsid (N), phosphoprotein (P) and RNAdependent RNA polymerase (L) proteins along with M2 protein are involved in RNA synthesis
[11,14,15].
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Figure 1.1. Model structure and proteins encoded by Human Metapneumovirus (HMPV). (a)
HMPV model structure indicating viral proteins encoded by (b) the viral genome.
Several animal models including mouse (see Table 1), cotton rat [16,17,18,19], hamster
[20,21,22], ferret [20] and nonhuman primate models [20,23,24] have been established to date to
study the immunopathology occurring after HMPV infection. Among them, the mouse model has
provided considerable knowledge towards our understanding of the HMPV-host interaction.

3

Thus this review focuses on the current knowledge of the immunity and immunopathology
induced by HMPV in the experimental mouse model of infection.
Table 1. Different conditions for mouse infection with HMPV

1.2 HMPV Infection in Mice
The experimental mouse model of HMPV infection has been established in several
mouse backgrounds using different HMPV strains at diverse inoculum concentrations, as shown
in Table 1.
Intranasal inoculation of mice with HMPV induces pulmonary inflammation
characterized by interstitial inflammation and/or peribronchiolar and perivascular cellular
infiltration [30,35,39,49], body weight loss with a peak of 15%–25% [16,25,32,34,41], altered
respiratory function characterized by a significant increase in airway obstruction on day 5 after
HMPV infection that could persist until day 21 [30], and lung viral titers that peak between day 3
to day 14 after HMPV infection [16,25,30,41].
4

However, some variations can be observed depending on the different experimental
conditions. For instance, intranasal inoculation of BALB/c mice with HMPV CAN98-75 resulted
in a biphasic lung viral replication with peaks at day 7 and day 14 [34,35] while infection of
BALB/c mice with any other HMPV strain led to a one-peak only of viral titer on or before day 5
after infection (Table 2). Based on the data from the reports included in Table 2, BALB/c mice
appear to be more permissive than C57BL/6 mice. Although, shedding of infectious virus
beyond the recovery phase has been rarely reported [34], detection of HMPV transcripts have
been found at day 154 [30] and 180 [34] after infection, suggesting that HMPV could persist in
the lung of infected animals since HMPV infection has been characterized as a localized
infection affecting just the airways but no other organs [35].

5

Table 2: Mouse susceptibility and permissibility to HMPV.

1.3 Lung Antiviral and Inflammatory Response
1.3.1 Innate Immunity
Innate immune responses to viral infections in the lung serve as the first line of defense
and it is activated upon recognition of the pathogen by immune cells in the respiratory tract. The
cellular barrier constituting neutrophils, macrophages, natural killer (NK) cells and dendritic
cells (DC) play a key role in the innate immune responses, which is triggered by the recognition
of pathogen associated molecular pattern (PAMP) by cell receptors called pattern recognition
receptors (PRRs) expressed in most cells of the respiratory tract. These pattern recognition
receptors are broadly classified into membrane bound Toll-like receptors (TLRs), C-type lectin
receptors (CLR), cytoplasmic RIG-I-like receptors (RLRs) and nucleotide-binding
oligomerization domain (NOD)-like receptors (NLRs) [56]. The recognition of viral PAMPs by
the cellular PRRs initiate the activation of signaling pathways leading to the production of
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cytokines and chemokines by the cells in the respiratory tract, that in turn regulate the
inflammatory and immune responses in the infected host.
1.3.2 Pattern Recognition Receptors and Signaling Pathways
We have recently demonstrated the importance of the RLR helicase melanoma
differentiation-associated gene 5 (MDA5) in the type I (α/β) and type III (λ) interferon (IFN)
production by HMPV infection [45]. In a model of MDA5-deficient mice (C57BL/6J
background) infected with HMPV CAN97-83, the lack of MDA5 resulted in a decreased viral
clearance, enhanced disease severity and pulmonary inflammation, and was necessary for the
production of IFN-α/β and IFN-λ2/3. Moreover, MDA5 regulated the production of cytokines
and chemokines in response to HMPV, demonstrating the critical role MDA5 plays in the control
of HMPV-induced disease [45]. Downstream of the MDA5 signaling pathway, this helicase
interacts with the adaptor molecule IFN-promoter stimulator 1 (IPS-1) at the mitochondrial
membrane in order to induce the expression of cytokines [57]. In that regard, studies in neonatal
IPS-1 deficient mice (C57BL/6 background) have shown that the absence of IPS-1 led to an
increased viral load and decreased production of IFN-β and IFN-λ2/3 at day 1 after HMPV
infection [58], indicating that IPS-1 contributes to the antiviral response and HMPV clearance.
Moreover, similar IFN response to HMPV infection in the absence of IPS-1 has been reported in
adult mice [59]. Thus, these findings confirm the key role for the MDA5 and IPS-1 signaling
pathway in the antiviral response against HMPV infection.
On the other hand, data of HMPV infection in C57BL/10ScSnJ Toll-like receptor 4
(TLR4) deficient mice have shown that absence of TLR4 resulted in a decreased inflammatory
response, disease severity, as well as IFN-α/β and cytokine production [48]. In line with those
data, the lack of myeloid differentiation protein response 88 (MyD88), an essential adaptor
7

molecule for TLR’s (except TLR3), led to a reduced lung inflammation and disease severity
compared to wild type mice. The absence of MyD88 also impaired the production of cytokines
and chemokines and the recruitment of DC, CD4 and CD8 T cells into the lungs of infected mice
[47]. Collectively, these studies indicate that TLR4 and MyD88 are key molecules that regulate
the HMPV-induced pulmonary inflammation and disease pathology in mice.
Signaling via PRRs ultimately leads to the activation of the transcription factors
interferon (IFN) regulatory factors (IRFs), which induce the expression of the interferons and
cytokine responses. Data in C57BL/6 mice have demonstrated that the expression of both IRF3
and IRF7 were necessary for the production of IFN-α/β [45]. In agreement with these results, in
HMPV-infected C57BL/6 neonatal mice, both IRF3 and IRF7 were necessary for the expression
of IFN-α4 and IFN-β. Moreover, the absence of both IRF3 and IRF7 exacerbated the Th1, Th2,
and Th17 lymphocyte responses as well as the recruitment of neutrophils, eosinophils, NK and
NK T cells in response to HMPV infection [58]. Similarly, the production of IFN-λ2/3 after
HMPV infection was regulated by the expression of IRF-7 in adult [49] and neonatal [58] mice.
However, the expression of IRF-3 was necessary for the production of IFN-λ2/3 in neonatal mice
[58] but it was dispensable when the IFN-λ2/3 was induced by HMPV in adult mice [49],
suggesting that the activation of the IFN-λ response by HMPV in adult and young mice is
differentially regulated by IRF-3 and IRF-7 expression. Interestingly, HMPV has also been
reported to inhibit the IFN responses [39,49]. Studies in BALB/c mice have demonstrated that
HMPV infection inhibits the poly-ICLC- (synthetic dsRNA, TLR3/RIG-I/MDA5 agonist) and
CpG-ODN- (TLR9 agonist) induced IFN-α production [39], suggesting that HMPV infection is
able to inhibit the activation of RLRs and TLRs in vivo. In addition, recent data have shown that
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HMPV G protein inhibits the production of IFN-λ2/3 in BALB/c mice after HMPV infection, at
least through the interference with the RIG-I/MDA5 pathway [49].
Based on the reported observations described above, HMPV-induced immune response is
regulated by the activation of selected PRRs. It appears that HMPV infection activates TLRs to
induce an inflammatory response while it subverts RLRs to alter the antiviral responses via the
inhibition of interferons. This immune subversion is attributed to the expression of HMPV G
protein. Taken together, experimental evidence demonstrates that HMPV is able to activate and
subvert antiviral signaling pathways, likely through different mechanisms. However, unresolved
pathways involved in activation or subversion of HMPV induced immune response, need further
elucidation. A detailed understating of HMPV induced recognition and signaling cascades is
crucial to developing effective therapeutics and vaccine strategies.
1.3.3 Cytokine Production
HMPV is known to induce in humans a profile of cytokines distinct to other respiratory
viruses such as respiratory syncytial virus (RSV), and influenza virus [60]. Although very scarce,
studies comparing HMPV and RSV infection are clinically relevant as RSV is the closest related
human paramyxovirus to HMPV [11]. In fact, symptoms between RSV and HMPV are
indistinguishable, ranging from mild cold-like symptoms to more severe clinical manifestations
like bronchiolitis or severe pneumonia that require hospitalizations [3,7,61]. However, some
aspects of the immune response elicited by these two viral pathogens are distinct. This was
demonstrated by the analysis of nasal washes from hospitalized infants showing that HMPV
infection induced significantly lower amounts of proinflammatory cytokines including IL-12, IL6, IL-8, TNF-α and IL-1β compared to RSV infection [60], suggesting that HMPV is a poor
inducer of inflammatory cytokines compared to RSV in infected infants. In line with these data,
9

research in the mouse model resembled the observation in human studies. Using BALB/c mice
infected with HMPV (CAN97-83) and compared to RSV (A2) side-by-side, HMPV induced a
weaker response of proinflammatory cytokines (IL-1α, IL-1β, IL-6, TNF-α, G-CSF) and
regulatory cytokines (IL-10, IL-12p70, IL-17). However, HMPV induced a stronger response of
IFN-α, GM-CSF, IL-18, CXCL1 (KC) and a sustained production of IL-12p40 [37]. In contrast
to this work, a study conducted in BALB/c mice using a clinical HMPV isolate (D03-574)
induced significantly higher levels of TNF-α, IL-6 and MCP-1 compared to RSV (A2) at day 4
and 7 post infection [44]. The discrepancies between these two studies in mice could be due to
the use of different virus strains and virus stock preparations.
The effect of HMPV on the IFN response has been further confirmed since experimental
observations indicated that HMPV induced a stronger response of IFN-β and IFN-λ2/3 when
compared to RSV infection in BALB/c mice [49]. However, levels of IFN-γ were induced
similarly by HMPV and RSV-infected BALB/c mice [44]. Additional data have also
demonstrated the capacity of HMPV to induce several cytokines in the lung, where a significant
induction of CCL2 (MCP-1) and CXCL1 (KC) on day 1 and IFN-γ, CCL5 (RANTES), CCL3
(MIP1α), and IL-4 on day 5 after HMPV infection has been observed [16,25]. Overall, these
findings suggest that HMPV infection induces a unique profile of cytokines and chemokines in
the lung of infected mice.
The regulatory effects that lung cytokines and chemokines exert in HMPV-induced
disease are still largely unexplored. In that regard, IL-12p40, an induced cytokine during HMPV
infection that remains sustained after the resolution of the disease [37] has been shown to be
critical to control disease severity by regulating cytokine production, inflammatory response and
mucin production in the lung. Using IL-12p40-/- mice infected with HMPV, showed an
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increased goblet cell formation, increased mucin gene expression in the airways and decreased
lung function. IL-12p40 was found to specifically regulate the expression of IFN-γ, IL-6,
CXCL10 (IP-10), CCL11 (eotaxin), CXCL1 (KC, IL-8 homolog) and CCL2 (MCP-1) in mice
infected with HMPV [46]. Furthermore, the level of expression of inflammatory cytokines after
HMPV infection appears to be altered in aged animals. For instance, TNF-α levels were
decreased ~7-fold in 19 moth-old HMPV-infected mice when compared to 4–6 week-old animals
[43] while IL-6 was increased in 18–19 month-old mice when compared to 6–8 week old mice
[62]. Also, HMPV infection alters the cytokine response to opportunistic bacterial infection in
the lung. Prior HMPV infection exacerbated the levels of TNF-α, IFN-γ, IL-1α, IL-1β, IL-6, IL12p40, IL-12 p70, IL-9, IL-10, IL-13, KC, G-CSF, GM-CSF, MCP-1 and MIP-1α
in Streptococcus pneumonia-infected mice and predisposed those animals to severe
pneumococcal infection [26]. The described cytokine patterns induced by HMPV infection are
crucial to understanding the underlying mechanisms in activation of the innate and adaptive
immune responses as well as the initiation and resolution of the inflammatory response and lung
viral clearance. However, the role of these cytokine pathways in promoting and modulating
inflammation and host immune responses in HMPV infection are still largely unknown. The use
of genetically modified mice will represent a critical tool to answer these relevant questions.
1.3.4 Dendritic Cells
Dendritic cells (DC) are professional antigen-presenting cells within the immune system.
Respiratory tract dendritic cells are present within airway epithelium, submucosa and associated
lung parenchymal tissue under resting conditions [63]. Their strategic localization at the site of
pathogen entry makes them particularly susceptible to initial viral invasion. After detection,
uptake and degradation of viruses, DC initiate immune responses via the secretion of interferon
11

(IFN), chemokines and proinflammatory cytokines, as well as the upregulation of a variety of
costimulatory molecules and receptors, a process globally known as cell maturation. After
maturation, DC efficiently present antigens and initiate adaptive immune response by migrating
into lymph nodes (LN) to activate the virus-specific T cell response [32]. To date, there have
been at least three major subsets of murine lung DC described. These include plasmacytoid DC
(pDC), the myeloid DC (also known a conventional DC, cDC), and the interferon-producing
killer dendritic cells (IKDC). DC have been reported to participate in the innate and adaptive
immune response to HMPV infections, indicating their critical role in the antiviral immunity to
this virus. Dendritic cells are susceptible to HMPV infection in vitro [64] and in vivo [40,65]. In
fact, HMPV activates mouse lung DC, and induces the upregulation of costimulatory molecules
and the secretion of several cytokines including IL-6, IFN-α, IFN-β and TNF-α [40]. HMPV
infection also induced the recruitment of pDC and IKDC which peaked by day 8 after infection.
The predominant subset recruited to the lung corresponded to cDC, and this remained the highest
subset for at least 18 days, beyond the acute phase of infection. CD103+ cDC substantially
decreased until three weeks after infection and returned to basal levels by week 8. Differential
production of cytokines by murine lung pDC and cDC infected with HMPV was also observed.
More interestingly, HMPV infection reduced the capacity of lung cDC to stimulate T cell
responses [40], which is in line with some reports in vitro using human DC that indicate that
HMPV alters their capacity to activate T cells [64,66].
1.3.5 Alveolar Macrophages
Alveolar macrophages (AMs) are known to be the first line of defense against respiratory
pathogens [67]. They reside in the pulmonary alveolus and survey the exposed airways to
contribute to the innate host defense against inhaled insults [68]. They are essential source of
12

immunomodulatory cytokines for host responses against lung infections and their depletion
results in impaired host response [67,69,70]. In fact, recent work has demonstrated that AMs
differentially control the antiviral response and airway inflammation in HMPV infection when
compared with RSV [69]. Using a BALB/c mouse model, AMs were depleted using clodronate
liposomes (L-CL2MBP) prior to HMPV infection. Depletion of AMs altered the HMPV-induced
disease since there was a reduced body weight loss, lung viral titer, decreased lung inflammation
and airway hyperresponsiveness (AHR). Moreover, the recruitment of CD4+ T lymphocytes was
significantly decreased following AM depletion. AMs are sources of pro inflammatory cytokines
and chemokines. In line with this, depletion of AMs resulted in significantly lower level of
cytokines including IL-1α, IL-1β, TNF-α, IL-6, GM-CSF, G-CSF, CCL4, IFN-α and IFN-β.
However, their depletion also induced an increased release of CCL3, CCL5, and IL-12p40 after
HMPV infection [69]. Thus, the results of this study indicate that the presence of alveolar
macrophages regulate and contribute to the HMPV-induced disease.
1.3.6 Natural Killer Cells
Another component of the innate immune system are the natural killer (NK) cells, which
are lymphocytes that respond to malignant tumors and intracellular pathogens including viruses.
Studies conducted by Alvarez et al. demonstrated that NK cells have a leading role in controlling
HMPV viral clearance [36]. Depletion of NK cells with anti-CD49b/Pan-NK cell monoclonal
antibody in BALB/c mice resulted in increased lung viral titers on days 7, 28 and 60 after
infection compared to NK cell competent mice. In contrast, work reported by Wen S. et al. in
C57BL/6 mice have demonstrated that NK cells do not contribute to HMPV clearance [51].
Lung NK cell numbers in infected mice were, however, increased as early as day 1 after HMPV
infection and peaked on day 3 compared to mock infected mice. Moreover, HMPV infection
13

induced activation of lung NK cells, as indicated by the upregulation of CD69. However,
depletion of NK cells using the anti-NK1.1 antibody did not result in changes in lung viral titers,
lung histopathology, or the numbers of CD4+ and CD8+ T lymphocytes. Suggesting that, NK
cells do not play a significant role in the host responses against HMPV, and that the clearance of
the viral infection requires different set of immune components in vivo. The discrepancies
between these two studies could be attributed to the use of different experimental conditions, as
detailed above. Thus, further work to fully define the role of NK cells in HMPV infection is
warranted.
1.4 Adaptive Immunity
Cell mediated immunity serves as an important barrier in the multi-step paradigm of
immune responses to pathogenic mechanisms. These responses function mainly by activation of
cytotoxic T-lymphocytes to induce apoptosis of virus-infected cells or by activating T helper
cells to stimulate other immune cells such as macrophages, B cells and NK cells and aid in the
production of distinct cytokine profiles to induce intercellular communication. Experimental
evidence with clone-specific induction of cytotoxic T cells [38] and experimental models with T
cell depletion studies [34,38,41] demonstrate the essential role of T lymphocytes in immune
surveillance and protection in HMPV infection.
Characterization of the T cell response against this virus has indicated that HMPV results
in an accumulation of virus-specific cytotoxic CD8+ T cells (CTL) in the lungs 7 days after
infection but not in regional lymph nodes or spleen. However, a strong memory response can be
recalled from the spleen at 21 days post infection [71]. Though both CD4+ and CD8+ T cells act
synergistically and play an indispensable role in both inflammatory responses and anti-viral
immunity, they have been found to induce different profile of cytokines after HMPV infection
14

[35]. During primary infection, depletion of either of the two T cell subsets, or in fact both of
them, caused reduced inflammation and body weight loss in HMPV-infected mice but were
required for viral clearance. These data suggest that primary HMPV infection induces lung
disease mediated, in large extent, by T cells while T cells are also necessary for the clearance of
primary HMPV infection [41]. Regarding the regulation of the T cell response during HMPV
infection, a recent study by Hastings et al., showed that type I IFN signaling is essential for the
development of functional HMPV specific CD8 T cells in the lungs using IFN-α receptor
deficient C57BL/6 mice [53]. Moreover, in aged mice, CD4+T cells appear to play an important
role in the exacerbated HMPV-induced disease. As demonstrated in 18-19 month-old BALB/c
mice which showed a significant increased numbers of IL-4-producing CD4+ T cells but no
change in the CD8+ T cell numbers when compared with younger mice [62], suggesting a Th2
skewing response in older mice after HMPV infection.
As for the role of T cells in HMPV reinfection, concurrent depletion of both CD4+ and
CD8+ T cells led to a decreased airway hyperresponsiveness (AHR) [41]. However, depletion of
CD4+ T cells alone during HMPV reinfection, unlike in CD8+ T cell-depleted mice, led to a
defective antibody response. Nevertheless, CD4+ T cell-depleted mice had undetectable
infectious virus after HMPV challenge and were protected from clinical disease, indicating that
protection can be provided by an intact CD8+ T cell response [41]. Interestingly, recent
observations indicate that the CD8+ T cell response is impaired during HMPV infection and
reinfection and that phenomenon appears to be regulated by the expression of the inhibitor
receptor programmed death-1 (PD-1) and programed death ligand-1 (PD-L1) [52,72,73]. These
findings indicate that a defective CD8+T cell response contributes to HMPV reinfection.
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Whether this effect characterizes the commonly observed HMPV reinfection in humans warrants
future research.
The understanding of the T cell response induced by HMPV vaccine candidates has
found their initial steps using the mouse model. The induction of CD8+ cytotoxic T cells by
peptide immunization in mice has proven to be protective against HMPV challenge in reducing
viral load and lung histopathology [38]. Likewise, immunization with Bacillus Calmette-Guerin
(BCG) strains expressing HMPV-phosphoprotein effectively induced a protective response
which was mediated by a Th1 T cell response [42]. Immunization with HMPV F-bearing viruslike particles (VLP) was also able to stimulate an HMPV specific CD8+ T cell response and
protected lungs from infection after HMPV challenge [50]. Further experimental studies in nonhuman primates and/or clinical trials are warranted in order to validate the immunological
observations in the mouse model towards vaccine development.
1.5 Conclusions
The experimental mouse model represents a valuable tool for in vivo research on HMPV
infection and has provided important information regarding the HMPV-induced disease and
detailed aspects of the immune response induced by HMPV infection. Although, inherent
limitations are observed in the mouse model when data are extrapolated to the natural human
infection, due to the availability of several gene deficient mice strains and multiple murine
specific antibodies, it provides a valued experimental small animal model that allows answering
critical questions that are necessary to our better understanding of the immune response and
disease pathogenesis of HMPV.
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CHAPTER 2
NEUTROPHILS REGULATE THE LUNG INFLAMMATORY RESPONSE
VIA γδ T CELL INFILTRATION IN AN EXPERIMENTAL MOUSE
MODEL OF HUMAN METAPNEUMOVIRUS INFECTION
2.1 Introduction
Neutrophils play an essential role in host defense against pathogens and represent the
most abundant leukocytes in human circulation [1, 2]. They play a critical role to protect against
microbial infections through multifaceted killing mechanisms [1] and to regulate innate as well
as adaptive immune responses [3]. Upon stimulation, neutrophils quickly migrate from
circulation to sites of damage and initiate crosstalk between resident and recruited immune cells,
including dendritic cells, T cells, B cells, macrophages, and NK cells, primarily through
secretion of cytokines and chemokines and also antigen presentation through MHC molecules
[4–6]. Neutrophils have been implicated in the antiviral immune response, as they represent an
early and abundant cell population recruited to sites of infection [7–10]. However, their role in
viral infections remains largely unknown, particularly in the respiratory tract where their effect
remains controversial. Studies of influenza infection in mice revealed that neutrophil depletion
exacerbates lung injury and development of severe disease [8, 11]. Furthermore, neutrophil
depletion before influenza infection, neutrophil depletion alters the magnitude of influenzaspecific CD8+ T cells and cytokine production, causing defective viral clearance [12]. These
findings confirm a beneficial and protective role of neutrophils during influenza infection in
mice. On the other hand, experimental evidence indicates that excessive recruitment
†
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of neutrophils to the airways during influenza infection in mice contributes to acute lung injury
by the formation of neutrophil extracellular traps [2].
Taken together, these contrasting findings warrant the need for further research on the
role of neutrophils in respiratory viral infections. HMPV is an enveloped, negative-sense ssRNA
paramyxovirus causing clinical syndromes, ranging from mild illnesses, such as the common
cold, to more severe symptoms, such as bronchiolitis and pneumonia [13, 14]. HMPV is
recognized as a significant global respiratory pathogen in young [15, 16], elderly [17, 18], and
immunocompromised individuals [19–21]. HMPV infection accounts for 5–15% of pediatric
hospitalizations with lower respiratory tract infections [22–26]. By 5 yr old, most children have
been infected by HMPV, and by the age of 25, virtually all adults have been exposed to the virus
[26, 27]. Research studies conducted over the last decade demonstrate that HMPV induces a
spectrum of immune responses, some of which contribute to the antiviral defense, whereas others
mount an evasion strategy by the virus for effective infection [28, 29]. However, several gaps in
the understanding of immune responses to HMPV resulted in limited success with the
development of effective vaccines and specific therapeutics against this clinically important viral
infection. Studies in mice have shown that neutrophils predominate in the airways early during
HMPV infection [30, 31]. However, it remains unknown whether these cells play a protective or
harmful role in the lung of infected mice, particularly in the context of immune response
regulation. Therefore, in the present work, we investigated how neutrophils shape HMPVinduced pathogenesis. We demonstrate that neutrophil depletion, achieved using mAb 1A8,
which binds specifically to Ly6Ghigh neutrophils [8, 32–36], led to increased pulmonary
inflammation and severe clinical disease (as indicated by an enhanced body weight loss and
clinical illness). However, neutrophils during HMPV infection did not contribute to lung viral
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clearance. Interestingly, neutrophil depletion during HMPV infection altered the recruitment of
lung γδ T cells and thus, that these cells contributed to HMPV-induced pathogenesis. Taken
together, these findings demonstrate that neutrophils play a protective and regulatory role in
HMPV-induced immune responses.
2.2 Methods
2.2.1 Virus
HMPV (strain CAN97-83) was grown and titrated in LLC-MK2 cells (ATCC, CCL7) in
the presence of trypsin (Worthington Biochemical, Lakewood, NJ, USA), as described
previously [37–39].
2.2.2 Infection of mice
BALB/c mice were purchased from Envigo (Indianapolis, IN, USA). δ-TCR KO
(B6.129P2-Tcrdtm1Mom/J) and WT mice were obtained from The Jackson Laboratory (Bar
Harbor, ME, USA). All animals were housed in specific pathogen-free conditions in accordance
with the Louisiana State University Institutional Animal Care and Use Committee. Eight- to 12wk-old mice were used in all experiments. Mice were anesthetized with a sub-lethal dose of
ketamine-xylazine and infected with 50 ml HMPV via the i.n. route, diluted in PBS at a final
administration dose of 1 x 107 PFUs. Mock-infected animals received 50 ml sterile PBS (herein,
referred to as mock).
2.2.3 Clinical illness score
A standardized 1–5 grading system was used to score mice for disease severity and
illness, as described previously [37, 40]. In brief, mice were assessed daily for visual signs of
clinical disease, including inactivity, ruffled fur, and hunched posture. In addition, daily
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determination of body weight was observed to monitor the progression of disease over the
experimental period.
2.2.4 Depletion of neutrophils
Mice were injected i.p. with 300 mg rat anti-mouse Ly6G (Clone 1A8; BioXCell, West
Lebanon, NH, USA) at the time of HMPV infection and every 48 h thereafter. All depletion
doses were administrated in sterile PBS. The anti-mouse Ly6G (1A8) antibody specifically and
efficiently depletes neutrophils in mice, as previously reported [8, 32–36]. Control animals
received an equivalent dose of purified rat IgG (Sigma-Aldrich, St. Louis, MO,
USA). Depletion of neutrophils in the airways was confirmed by flow cytometry.
2.2.5 Mouse sample collection
Mice were euthanized by an i.p. injection of ketamine and xylazine and exsanguinated
via the femoral vessels, as previously reported [37, 39, 41]. To collect the BALF, lungs were
flushed twice with 1 ml PBS, as previously described [37, 39]. Cell-free supernatants were stored
at -75°C for cytokine analysis. For histologic analysis, lungs of mice were perfused and fixed in
10% buffered formalin and embedded in paraffin. Lung tissue sections were stained with H&E
and visualized by bright-field microscopy using the highthroughput slide-scanner NanoZoomer
with a 203 objective (numerical aperture of 0.75) and the NanoZoomer digital pathology view
software (both from Hamamatsu Photonics, Hamamatsu City, Japan), as previously reported
[39]. For viral gene-expression experiments, lung tissue was snap frozen in liquid nitrogen and
stored at -75°C until analysis. For lung cell analysis, lungs were collected and kept on ice until
their digestion with collagenase to obtain single-cell suspensions, as previously described [42].
For viral titration, total lungs were collected and snap frozen in liquid nitrogen and stored at 75°C until analysis.
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2.2.6 Pulmonary inflammation
For histologic analysis, a blind analysis and scoring for cellular infiltration were
performed, as previously described [39]. In brief, inflammatory infiltrates were scored by
enumerating the layers of inflammatory cells surrounding the vessels and bronchioles. The
number of abnormal perivascular and peribronchial spaces divided by the total perivascular and
peribronchial spaces was the percentage reported as pathology score.
2.2.7 Flow cytometry
BALF and lung single-cell suspensions were incubated with anti-CD16/CD32 (Clone
2.G2) antibody at 4°C for 30 min before staining with the following specific antibodies: anti-Gr1 (Clone RB6-8C5), anti-CD11b (Clone M1/70), anti-CD8a (Clone 53-6.7), anti-CD4 (Clone
RM4-5), anti-CD3e (Clone 145-2C11), anti- B220 (Clone RA3-6B2), anti-CD19 (Clone 1D3),
anti- γδ TCR (Clone GL3), and anti-MHC class II (Clone 2G9); all from BD PharMingen (San
Jose, CA, USA), and anti-CD11c (Clone N418) and anti-F4/80 (Clone BM8); from eBioscience
(San Diego, CA, USA). Cells were incubated for an additional 30 min at 4°C and washed with
PBS/1% BSA before fixing them with 1% paraformaldehyde. Cells were analyzed using a
FACScan flow cytometer (BD Biosciences, San Jose, CA, USA) and FlowJo software (version
7.6.3; Tree Star, Ashland, OR, USA).
2.2.8 Cytokines and chemokines
Quantification of cytokine and chemokine release in BAL samples was determined using
the Milliplex MAP Mouse Cytokine 32 Plex assay (EMD Millipore, Billerica, MA, USA),
according to the manufacturer’s instructions. The assay range of sensitivity of is 3.2–10,000
pg/ml.
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2.2.9 Lung viral replication
Homogenized lung tissue samples were tested for viral titer. Serial 2-fold dilutions of the
supernatant were tested by plaque assay on LLC-MK2 cells under methylcellulose overlay.
Plaques were visualized 6 d later by HRP staining, as previously reported [38, 39].
2.2.10 Real-time qRT-PCR
RNA from lung tissues was extracted using the RNeasy Plus kit (Qiagen, Hilden,
Germany). Viral gene expression was determined using specific primers and probes (Integrated
DNA Technologies, Coralville, IA, USA). qRT-PCRs were run on a 7900HT Fast Real-Time
PCR System, following the manufacturer’s suggested cycling parameters (Thermo Fisher
Scientific, Waltham, MA, USA). The comparative cycle threshold method was used to quantitate
the expression of target genes, and results were normalized to the endogenous GAPDH and
expression levels of transcripts from mock-infected tissues.
2.2.11 Statistical analysis
Statistical significance for the comparison of 2 sets of values was performed using a
Student’s t-test (two-tailed, two-sample equal variance). A one-way ANOVA was used to
compare 3 or more sets of values, followed by a Tukey-Kramer test to correct for multiple
comparisons using Graph Pad InStat 3 (GraphPad Software, La Jolla, CA, USA). P # 0.05 was
considered statistically significant.
2.3 Results
2.3.1 HMPV induces a robust response of neutrophils
To define the importance of neutrophils in HMPV infection, we first assessed the
infiltration of neutrophils in mice infected with HMPV at d 1, 4, and 7 after infection. BAL
samples were collected, and cytospin analysis was performed in Wright Giemsa stained
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preparations. Analysis of cytospin preparations revealed a predominant neutrophil infiltration in
the airways in the infected mice compared with mock-infected ones (Fig. 2.1A). Furthermore, a
more specific identification of neutrophils was assessed by flow cytometry analysis, where
neutrophils were identified as F4/802/Gr-1+/CD11b+. Our flow cytometry data indicate that in
the alveolar spaces, the prevailing cells after d 1 of HMPV infection were neutrophils (Fig.
2.1B). Quantification of the neutrophils infiltrated into the alveoli indicate that HMPV induced a
significant influx of these cells into the airways as early as d 1 p.i. and decreased over time;
however, up until d 7 p.i., the percentage (Fig. 2.1C) and number (Fig. 2.1D) of neutrophils
remain increased (0.88 ± 0.2 x105) above the basal numbers found in mock-infected mice (0.03 ±
0.2 x105).
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Figure 2.1. Neutrophil recruitment following inoculation of mice with HMPV. BALB/c mice
were infected with 107 PFU of HMPV. BALF was collected at different time points, and
neutrophils were quantified using flow cytometry. (A) Differential cell images stained by
Wright-Giemsa showing cellular influx in BAL on d 1 from mock and HMPV-infected mice
(original magnification, 403). (B) Flow cytometry analysis of neutrophil influx in BAL at d 1
after infection. (C) Percentage of neutrophils in BAL at d 1, 4, and 7 after infection. (D) Total
number of neutrophils in BAL at d 1, 4, and 7 after infection. Means ± SEM are shown; n = 6
mice/group. Control mice were mock infected with PBS. *P < 0.05, **P < 0.01.
2.3.2 Efficient depletion of neutrophils in vivo during HMPV infection
To investigate further the role of neutrophils in HMPV infection, we specifically depleted
neutrophils in mice [8, 32–35] using multiple doses of the anti-Ly6G mAb (Fig. 2.2A). Mice
were treated i.p. with 300 mg anti-Ly6G (Clone 1A8) on d 0, 2, 4, and 6 of infection. Likewise,
control mice were treated with 300 mg rat IgG2a isotype antibody control. The efficiency of
neutrophil depletion was confirmed by flow cytometry analysis at d 7 p.i. in BAL (Fig. 2.2C) and
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lung (Fig. 2.2D) samples. We observed that treatment of mice with the anti-Ly6G antibody
resulted in a significant reduction in HMPV-induced neutrophil infiltration in the alveolar spaces
of .95% compared with those treated with the isotype antibody (Fig. 2.2C). Likewise, we
observed a significant depletion of neutrophils in the lungs of infected mice, as the numbers of
neutrophils in HMPV-infected mice were reduced from 33.6 ± 2.1 x105 in the competent mice to
7.1 ± 1.1 x105 in the depleted mice. After depletion, the number of neutrophils in the lung of
HMPV-infected mice resembled the amount of neutrophils found in the mock-infected ones of
7.9 ± 1.1 x105 (Fig. 2.2D). These results indicate that the neutrophil depletion strategy was
efficient.
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Figure 2.2. Efficiency of neutrophil depletion in vivo during HMPV infection. BALB/c mice
were treated with isotype (IgG) or anti-Ly6G antibody before and p.i. with HMPV. (A)
Treatment plan for depletion of neutrophils. (B) Depletion of neutrophils in BAL was confirmed
by flow cytometry on d 7 after infection. Total neutrophils in infected mice after depletion in (C)
BAL and (D) lung; n = 8 mice/group. Control mice were mock infected with PBS. ***P < 0.001.
2.3.3 Depletion of neutrophils delays disease recovery and exacerbates lung inflammation
Once the conditions for neutrophil depletion were established, and the depletion
efficiency was confirmed, we determined the role of neutrophils in the clinical disease and
inflammation after HMPV infection. Mice were treated with anti-Ly6G or isotype control
antibodies, according to the neutrophil depletion strategy mentioned above (Fig. 2.2A). After
HMPV infection, mice were monitored daily for signs of disease and changes in body weight.
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Uninfected mice treated with either anti-Ly6G mAb or isotype control did not display any signs
of sickness or weight loss over the 7 d monitoring period, indicating that depletion of neutrophils
alone does not lead to clinical illness (Fig. 2.3A and C). On the other hand, in HMPV-infected
mice, depletion of neutrophils resulted in an enhanced disease severity compared with
undepleted mice (Fig. 2.3A). This was more evident at d 3 p.i. and was statistically significant at
d 6 and 7. Signs of HMPV-induced disease peaked between d 2 and 3 in both groups of infected
mice. However, competent mice fully recovered by d 6, whereas depleted mice remained sick at
least by d 7, the last time point tested. An evident difference between the competent and depleted
mice after 7 d of HMPV infection is depicted in Fig. 3B. In line with these observations,
depletion of neutrophils showed an enhanced body weight loss that was statistically significant
by d 5 and continued through d 7 (Fig. 2.3C). Furthermore, we investigated whether the signs of
disease were concomitant with other measurable parameters in the infected mice, such as lung
inflammation. For that purpose, lung tissues were collected and fixed on d 7 after infection (peak
of inflammation in HMPV infection [30, 39]), and lungs were processed as described in
Methods. Lung tissue sections were stained with H&E and analyzed for abnormal cellular
infiltration in perivascular and peribronchial spaces. Results shown in Fig. 2.3D revealed
significantly increased lung inflammation, represented as pathology score, in depleted mice
infected with HMPV (33%) compared with competent mice after HMPV infection (20.7%).
Together, these data demonstrate that neutrophils are necessary to reduce illness and
inflammation during HMPV infection.
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Figure 2.3. Neutrophil depletion enhances body weight loss and augments disease severity and
lung pathology in HMPV infection. BALB/c mice were treated with isotype or anti-Ly6G
antibody before and p.i. with HMPV. (A) Infected mice were scored for illness based on disease
severity. (B) Signs of sickness in isotype or anti-Ly6G treated and HMPV-infected mice on d 7
after infection. (C) Body weight loss. (D) Pathology score from lung sections obtained at d 7
after HMPV infection. Means ± SEM are shown; n = 8 mice/group. *P < 0.05, **P < 0.01, ***P
< 0.001.
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2.3.4 Neutrophil depletion does not alter lung HMPV titers
Next, we examined whether the exacerbated HMPV-induced disease and inflammation observed
in the depleted mice were a consequence of an altered lung viral replication. Mice were treated
with isotype or anti-Ly6G antibody and infected with HMPV, as described above. Lung tissues
were collected at d 4 and 7 after HMPV infection. Sampling times were designed based on the
lung viral titer, which peaks between d 4 and 5 after HMPV infection but is almost cleared by d 7
[30, 39]. By testing d 4 after infection, we tested the peak of the viral titer; by testing d 7, we
sought to determine whether there was any delay in the lung virus clearance as a consequence of
neutrophil depletion. The presence of virus was assessed by quantifying the HMPV N gene
expression by qRT-PCR and the yield of infectious virus by plaque assay. Our results shown in
Fig. 2.4A indicate that there was no difference in the viral gene expression at d 4 and day 7 after
HMPV infection. This observation was confirmed by plaque assay, where no change in the viral
titers was observed between the depleted or competent mice infected with HMPV at d 4 p.i. (Fig.
2.4B).
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Figure 2.4. Depletion of neutrophils does not affect lung viral titer in HMPV-infected mice.
Whole lungs and lung tissues from depleted or competent mice infected with HMPV were
collected on d 4 and 7 p.i. (A) HMPV N gene relative expression in lung quantified by qRTPCR. (B) Viral titer was determined in lung homogenates by plaque assay. Means 6 SEM are
shown; n = 6 mice/group.
2.3.5 Depletion of neutrophils increases the release of lung cytokines and chemokines after
HMPV infection.
To delineate further the effect of neutrophils in the regulation of HMPV-induced
inflammatory response, the concentration of cytokines and chemokines was measured in
neutrophil-depleted mice and compared with those from neutrophil-competent mice. Mice were
infected i.n. with HMPV, and BAL samples were obtained from each group at d 7 after infection.
The level of cytokines and chemokines in BAL was measured using a multiplex cytokine
detection system. As shown in Fig. 2.5, depletion of neutrophils led to an increased response of
inflammatory and immunoregulatory cytokines after HMPV infection. We observed a 2-fold
increase in the production of CCL11 (eotaxin), whereas IL-12p40, CXCL9 (monokine induced
by IFN-g), CXCL2 (MIP 2), IL-1b, TNF, and IL-17 were incremented 1.4-fold in depleted mice
compared with competent ones. The most up-regulated chemokines after neutrophil depletion
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were CCL2 (MCP-1) and CXCL1 (KC, IL-8 homolog), which were increased 3-fold compared
with nondepleted mice.

Figure 2.5. Pulmonary inflammation in neutrophil depleted mice infected with HMPV. BALB/c
mice were treated with isotype (IgG) or anti-Ly6G antibody before and p.i. with HMPV or
mockinfected with PBS. BAL samples from each group of mice were assessed for
cytokine/chemokine production by a multiplex cytokine detection system; n = 8–18 mice/group.
*P < 0.05, **P < 0.01, ***P < 0.005.
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2.3.6 Neutrophils regulate lung γδ T cell recruitment during HMPV infection
As described above, depletion of neutrophils induced an exacerbated inflammatory
response in the lung after HMPV infection (Fig. 2.3D). Therefore, we also sought to characterize
the cell subsets infiltrated in the lung affected by neutrophil depletion. For that, lungs were
harvested at the peak of inflammation (d 7 p.i.). Lung single-cell suspensions were prepared
from mock-infected, neutrophil-depleted, and undepleted mice with HMPV infection. The
infiltration of myeloid cells, such as macrophages and dendritic cells, as well as the lymphocyte
response, including B and T cells (CD4+, C8+, and γδ), was analyzed. As shown in Fig. 2.6, the
depletion of neutrophils did not impact the total number of macrophages or dendritic cells (Fig.
2.6A). Likewise, the total number of CD4+ T, CD8+ T, and B cells (Fig. 2.6B) was also not
affected upon neutrophil depletion. Interestingly, the depletion of neutrophils had a significant
impact on the infiltration of γδ T cells in the lung. We observed an increased number of these
cells after HMPV infection in the neutrophil-depleted mice.
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Figure 2.6. Neutrophil depletion alters lung T cell responses during HMPV infection. BALB/c
mice were treated with isotype (IgG) or test antibody (anti-Ly6G) before and p.i. with HMPV.
Lung single-cell suspensions were stained for (A) myeloid populations (macrophages, dendritic
cells) and (B) lymphocyte populations (CD4+, CD8+, B cells, and γδ T cells). Means ± SEM are
shown; n = 4–15 mice/group. ***P < 0.001.
2.3.7 HMPV infection induces γδ T cell recruitment to the lung, and their deficiency leads to
reduced lung pathology
Based on the above observations, the depletion of neutrophils led to an exacerbated
HMPV-induced pathogenesis and also to an increased number of γδ T cells in the lung. We
hypothesized, based on these findings, that γδ T cells could contribute to the inflammatory
response induced by HMPV. We first determined the effect of HMPV in γδ T cell recruitment.
Data shown in Fig. 2.7A indicate that HMPV is capable of inducing an increase in γδ T cell
numbers, which were significantly recruited (13.6 x 104 ± 1.1) by d 5 after HMPV infection and
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remained increased (15.7 x 104 ± 1.2) until d 15 after infection, as compared with baseline levels
in mock-infected mice (6.7 x 104 ± 1.1). To evaluate the contribution of γδ T cells in the
inflammatory response induced by HMPV infection, we infected TCR-δ KO mice (mice lacking
the d chain of the TCR) or WT mice with HMPV. At d 7 after infection, lungs were collected,
and tissue sections were processed for further evaluation, as described above. Lung
histopathological analysis revealed that no airway inflammation was observed in mock-infected
WT or KO mice (Fig. 2.7C, left and second to left). However, HMPV infection induced a
cellular infiltration in the perivascular and peribronchial spaces of WT mice (Fig. 2.7C, second
to right), which was reduced in the TCR-δ KO mice (Fig. 2.7C, right). Quantification of the
pulmonary inflammation, represented as pathology score, indicated that inflammation in the
respiratory tract of TCR-δ KO mice was significantly decreased compared with WT animals
(Fig. 2.7B).
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Figure 2.7. Recruitment and role of γδ T cells during HMPV infection. (A) C57BL/6 mice were
infected i.n. with HMPV and lungs harvested at d 1, 3, 5, 7, and 15 after infection. Lung single
cell suspensions were stained for γδ T cells and quantified using flow cytometry. (B) TCR-δ or
WT C57BL/6 mice were infected with HMPV and lung sections obtained at d 7 after infection
for histopathology analysis. Lung pathology is represented as percentage pathology score. (C)
Representative scans of lung tissue corresponding to the pathology score from the indicated
treatment. Arrows indicate cells infiltrating the perivascular spaces. Original scale bars, 0.4X = 5
mm; 20X = 50 mm. *P < 0.05, **P < 0.01.
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2.4 Discussion
Neutrophils are the most abundant leukocytes in human circulation and are considered a
first line of defense against invading bacterial and fungal infections [43, 44]. Indeed, neutrophils
are known to be markedly increased and to protect against these pathogens [45]. However, the
role of neutrophils in viral infections remains largely understudied, particularly in the respiratory
tract, where they are recruited after viral infections, as shown in experimental models [11, 30,
46] and in humans [9, 10, 47, 48]. In fact, it has been recently reported that HMPV induces
neutrophil influx in the airways, as demonstrated by increased infiltration of these cells in
nasopharyngeal aspirates from infected infants [9], which underline the importance of these cells
in HMPV infection. In the current study, we demonstrated that neutrophils were the predominant
cell population in the lungs of infected mice as early as d 1 after HMPV infection, and their
infiltration in the lungs remained significantly higher than that of the uninfected control mice at d
7 after infection (Fig. 2.1). These data are in line with those previously reported in HMPVinfected mice, where the number of neutrophils increased during the first 2 d of infection [30, 49]
and gradually decreased by d 4 and 7 after infection [30, 50]. Therefore, these findings led us to
speculate that neutrophils play a role in HMPV infection.
To investigate that hypothesis, we used a model of neutrophil depletion using several
doses of the anti-Ly6G mAb (1A8; Fig. 2.2), which specifically depletes neutrophils [8, 32]. In
this model, we observed that depletion of neutrophils led to an increased disease severity and
inflammation, as demonstrated by an increase in clinical illness, body weight loss, and
exacerbated lung inflammation (Fig. 2.3), which suggests a beneficial role of neutrophils in
HMPV infection. These data are in agreement with those reported from mice infected with other
respiratory viruses, such as influenza virus, where the depletion of neutrophils under similar
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conditions resulted in an enhanced body weight loss, increased pulmonary inflammation, and
reduced survival [8, 11]. However, neutrophil depletion did not have an effect on HMPV lung
titers and viral clearance, as there was no significant difference between the depleted and
competent mice in the viral gene expression and infectious virus at d 4 and 7 after HMPV
infection (Fig. 2.4). A similar effect has been observed in the close related human paramyxovirus
RSV infection, where depletion of neutrophils in mice did not alter the lung viral titers in the
infected animals but resulted in altered levels of mucus and cytokines, such as TNF and IL-13
[51]. Therefore, it appears that the increased disease severity and pulmonary inflammation
observed in the depleted mice were not results of higher lung viral titers in the depleted mice and
that neutrophils regulate the inflammatory response to HMPV infection independently of viral
load. In that regard, it has been reported that a high HMPV viral load can be associated to greater
disease severity on infected children [52], but recent findings indicate also that viral load does
not have a significant impact on disease severity in children infected with HMPV [53]. Thus,
further research is needed to define the controversial relationship between viral load and HMPVinduced disease severity and progression. Increased production of inflammatory cytokines in a
moderate fashion results in a beneficial and effective mechanism to fight infections; however, an
exacerbated or excessive inflammatory response is harmful to the host and could lead to tissue
damage. We observed that depletion of neutrophils significantly exacerbated the production of
cytokines and chemokines after HMPV infection. Increased levels of IL-1b, TNF, IL-17,
CXCL2, CCL11, IL-12p40, CXCL1, CXCL2, and CXCL9 were detected, which correlate with
the exacerbated pulmonary inflammation observed in the depleted mice. Data obtained in
neutrophil depleted mice infected with RSV indicate, however, that neutrophil depletion reduced
the amount of TNF after d1 of RSV infection [51]. This discrepancy may be attributable not only
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to the different virus used but also to the day that the samples were collected. TNF production
after HMPV infection peaks as early as d 1 after infection, but RSV induces higher levels of TNF
than HMPV [54]. In the present work, we analyzed the production of cytokines and chemokines
at d 7 after infection, as that was the day we also observed an increased pulmonary
peribronchiolar inflammation. The role of neutrophils in regulating the recruitment and
activation of other cells in the immune system, such as T cells, is well documented [3, 36, 55].
The heterogeneity of the neutrophil population is responsible for their different effects on T cells,
as recent reports support the existence of several neutrophil subsets [56–58], including after
respiratory viral infections [10]. Thus, a subset of mature neutrophils can activate the immune
system and clear the infection, whereas other subsets of neutrophils can induce
immunosuppression or are inefficient in antimicrobial immune activities [56, 59]. In this work,
we observed a significant increase in lung γδ T cells when mice were treated with the anti-Ly6G,
suggesting a suppressive effect of pulmonary neutrophils on γδ T cells after HMPV infection. In
that regard, the suppression of γδ T cells by human neutrophils has recently been demonstrated
in different in vitro models and is known to be achieved by several mechanisms [60–62].
Interestingly, in our model of HMPV infection, the effect of neutrophils appeared to be selective
to γδ T cells, as we observed no difference in the number of other immune cells (CD4 T cells,
CD8 T cells, B cells, macrophages, and dendritic cells) in the lungs of infected animals when
compared between the competent and depleted mice. Studies in pulmonary experimental
infection with the opportunistic fungal pathogen Cryptococcus neoformans have also revealed
that depletion of neutrophils led to increased numbers of γδ T cells in the lung, which in turn,
were responsible for the increased production of IL-17 after neutrophil depletion [43], indicating
that neutrophils inhibit γδ T cell function. Likewise, in our work, we also observed significantly
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higher levels of IL-17 and increased numbers of γδ T cells in the lungs of neutrophil-deficient
mice, which coincided with increased levels of CXCL1, likely produced by lung γδ T cells [63].
This suggests that neutrophils may indeed exert a regulatory effect on γδ T cells after HMPV
infection. Future studies are needed to demonstrate specifically a suppressive subset of
neutrophils during HMPV infection. γδ T cells are a subset of nonconventional T lymphocytes
that play a critical role in linking the innate and adaptive arms of the immune system [64].
Different subsets of γδ T cells are widely distributed in the lung [65], and pulmonary γδ T cells
contribute to the mucosal immunity and protection of the lungs [66, 67]. In our model of HMPVinfected mice, we observed that pulmonary γδ T cells are increased after d 5 of infection and that
accumulation remained high by d 15 after HMPV infection. Compared with HMPV infection,
reported experiments in RSV-infected mice indicate that the accumulation of γδ T cells peaks in
lower numbers by d 4 after infection, and it returns to basal levels by d 15 after infection [66].
Moreover, after HMPV infection, TCR-δ KO mice exhibited a decreased pulmonary
inflammation compared with WT mice, indicating that these cells play an important role in the
inflammatory response induced by HMPV. Similar results were found in RSV-infected mice
[66], as well as in a model of respiratory bacterial infection (Staphylococccus aureus) [68],
where γδ T cells also contributed to the inflammatory response in the lungs. In conclusion, the
current data represent the first evidence that neutrophils have a critical regulatory role in HMPVinduced pathogenesis. Our results indicate that neutrophils contribute to the control of disease
severity and pulmonary inflammatory response by regulating the accumulation of γδ T cells to
the site of infection in the HMPV-infected mice. Whereas the experimental mouse model of
HMPV infection has intrinsic limitations, it represents a valuable experimental small animal
model that allows exploring relevant aspects of the HMPV-induced pathogenesis and immune
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responses. Future studies to define the mechanism of regulation between neutrophils and γδ T
cells, as well as to investigate further the role of γδ T cells in HMPV infection are warranted.
Overall, these findings enhance our understanding of the HMPV-induced pathogenesis and
highlight the importance of neutrophils in regulating the fine line between disease and protection
to HMPV infection.
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CHAPTER 3
ROLE OF GAMMA DELTA (γδ) T CELLS IN HMPV INFECTION
3.1 Introduction
HMPV is a pneumovirus causing symptoms, varying from mild illness such as common cold to
severe conditions such as pneumonia [1, 2]. Innate immune cells, especially neutrophils have
been known to play a key role in γδ T cells induced airway inflammation during HMPV
infection [3]. Apart from innate immune system response in HMPV infection, gamma delta TCR
carrying T cells, also known as γδ T cells, also play an essential role in mucosal host defense
towards viral infection [4]. In fact, we have recently reported that depletion of neutrophils leads
to an increased number of γδ T cells in the lung of mice infected with HMPV and that γδ T cells
control lung inflammatory response in the infected mice [3], as described in Chapter 2. Those
findings led to us to hypothesize that γδ T cells play a critical role in HMPV-induced
pathogenesis. Therefore, in this chapter I focused on the study of the effect of γδ T cells on
disease parameters such as lung viral replication and the role of these cells on other cells of the
innate and adaptive immune systems.
3.2 Materials and methods
3.2.1 Virus
HMPV (strain CAN97-83) was grown and titrated in LLC-MK2 cells (ATCC, CCL7) in
the presence of trypsin (Worthington Biochemical, Lakewood, NJ, USA), as described
previously [12–14].
3.2.2 Infection of mice
BALB/c mice were purchased from Envigo (Indianapolis, IN, USA). δ-TCR KO (B6.129P2Tcrdtm1Mom/J) and WT mice were obtained from The Jackson Laboratory (Bar Harbor, ME,
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USA). All animals were housed in specific pathogen-free conditions in accordance with the
Louisiana State University Institutional Animal Care and Use Committee. Eight- to 12-wk-old
mice were used in all experiments. Mice were anesthetized with a sublethal dose of ketaminexylazine and infected with 50 ml HMPV via the i.n. route, diluted in PBS at a final
administration dose of 1 x 107 PFUs. Mock-infected animals received 50 ml sterile PBS (herein,
referred to as mock).
3.2.3 Mouse sample collection
Mice were euthanized by an i.p. injection of ketamine and xylazine and exsanguinated
via the femoral vessels, as previously reported [12, 14, 16]. To collect the BALF, lungs were
flushed twice with 1 ml PBS, as previously described [12, 14]. Cell-free supernatants were stored
at 75°C for cytokine analysis. For viral gene-expression experiments, lung tissue was snap frozen
in liquid nitrogen and stored at 75°C until analysis. For lung cell analysis, lungs were collected
and kept on ice until their digestion with collagenase to obtain single-cell suspensions, as
previously described [17]. For viral titration, total lungs were collected and snap frozen in liquid
nitrogen and stored at 75°C until analysis.
3.2.5 Flow cytometry
Lung single-cell suspensions were incubated with anti-CD16/CD32 (Clone 2.G2)
antibody at 4°C for 30 min before staining with the following specific antibodies: anti-Gr-1
(Clone RB6-8C5), anti-CD11b (Clone M1/70), anti-CD8a (Clone 53-6.7), anti-CD4 (Clone
RM4-5), anti-CD3e (Clone 145-2C11), anti- B220 (Clone RA3-6B2), anti-CD19 (Clone 1D3);
all from BD PharMingen (San Jose, CA, USA), and anti- anti-F4/80 (Clone BM8); from
eBioscience (San Diego, CA, USA). Cells were incubated for an additional 30 min at 4°C and
washed with PBS/1% BSA before fixing them with 1% paraformaldehyde. Cells were analyzed
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using a FACScan flow cytometer (BD Biosciences, San Jose, CA, USA) and FlowJo software
(version 7.6.3; Tree Star, Ashland, OR, USA).
3.2.6 Cytokines and chemokines
Quantification of cytokine and chemokine release in BAL samples was determined using
the Milliplex MAP Mouse Cytokine 32 Plex assay (EMD Millipore, Billerica, MA, USA),
according to the manufacturer’s instructions. The assay range of sensitivity of is 3.2–10,000
pg/ml.
3.2.8 Real-time qRT-PCR
RNA from lung tissues was extracted using the RNeasy Plus kit (Qiagen, Hilden,
Germany). Viral gene expression was determined using specific primers and probes (Integrated
DNA Technologies, Coralville, IA, USA). qRT-PCRs were run on a 7900HT Fast Real-Time
PCR System, following the manufacturer’s suggested cycling parameters (Thermo Fisher
Scientific, Waltham, MA, USA). The comparative cycle threshold method was used to quantitate
the expression of target genes, and results were normalized to the endogenous GAPDH and
expression levels of transcripts from mock-infected tissues.
3.2.9 Statistical analysis
Statistical significance for the comparison of 2 sets of values was performed using a
Student’s t-test (two-tailed, two-sample equal variance). A one-way ANOVA was used to
compare 3 or more sets of values, followed by a Tukey-Kramer test to correct for multiple
comparisons using Graph Pad InStat 3 (GraphPad Software, La Jolla, CA, USA). P # 0.05 was
considered statistically significant.
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3.3 Results
3.3.1 Lack of γδ T cells alter lung chemokine/cytokine profile
As we previously observed lack of γδ T cells leading to reduced lung inflammation
during HMPV infection, we sought to identify the cells inflammatory mediators behind this
mechanism. For this, the concentration of cytokines and chemokines were measured in mockinfected vs HMPV infected WT vs γδ-KO mice. WT or γδ TCR KO mice were infected i.n. with
HMPV or PBS (Mock), and BAL samples were obtained from each group at d 7, after infection.
As shown in Figure 3.1, we observed a robust increase in chemokine and cytokine levels in the
BAL samples from WT mice that were HMPV infected compared to the mock infected WT or
KO mice. Even though the levels of chemokines or cytokines in HMPV infected KO mice BAL
samples appear elevated compared to the mock-infected controls, they were lower than HMPVinfected WT mice. All the cytokines and chemokines that had changes in their levels were
primarily known for their role in neutrophil trafficking and activation. Only IL-6, a proinflammatory cytokine, was significantly reduced in the HMPV infected γδ TCR KO mice
compared to the HMPV infected WT mice. This is in line with previous studies suggesting an
IL-6 mediated activation of γδ T cells in airway inflammation [18].
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Figure 3.1. γδ T cells regulate lung cytokine/chemokine profile in HMPV infected mice. WT or
KO mice were infected with HMPV or PBS and BAL collected at day 7 after infection. BAL
samples from each group of mice were assessed for cytokine/chemokine production by a multiPlex cytokine detection system. n = 4–10 mice/group. Mean ± SEM are shown. * p < 0.05.
3.3.1 Role of γδ T cells in viral clearance
To further investigate whether the exacerbated HMPV-induced inflammation in the γδ
TCR KO mice was a result of altered viral replication, we performed lung viral gene expression.
For this, WT or KO mice were infected with HMPV, as mentioned above. At d 4 or 7, after
HMPV infection, lung tissues were obtained and tested for the viral gene expression [15,19]. The
presence of virus was analyzed by quantifying HMPV N gene expression using qRT-PCR. As
shown in Figure 3.2, we observed a trend of increase in the HMPV N gene expression on d 4, p.i.
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in the KO mice compared to WT mice (one-tailed P value is 0.1), but no changes in the HMPV
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Figure 3.2. Lack γδ T cells alter lung viral gene expression in HMPV-infected mice. Lung
tissues from WT or KO mice infected with HMPV were collected on d 4 and 7 p.i. HMPV N
gene relative expression in lung was quantified by qRT-PCR . Means 6 SEM are shown; n = 3-6
mice/group.
3.3.1 Lack of γδ T cells alter lung neutrophil influx
As described above, knockout of γδ TCR resulted in decreased proinflammatory
cytokines (Fig. 3.1). To see the population of immune cells affected by this change in
cytokine/chemokine profile, we pursued characterizing the cell subsets infiltrated in the lung
affected by γδ TCR-KO. At d 7, p.i., which is peak of inflammation in HMPV infection in mice,
we harvested lungs and obtained lung single-cells suspensions from WT or KO mock infected or
HMPV infected mice. We then analyzed the infiltration of granulocytic cells, such as
neutrophils, as well as lymphocytic response including CD4+ or CD8+ T cells. As shown in
Figure 3.3, γδ TCR knockout did impact the total number of neutrophils. However, the total
number of CD8+ T cells or CD4+ T cells in the lung showed marginal changes. Thus, lack of γδ
T cells alters lung neutrophilic response.
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Figure 3.3. γδ T cells regulate lung neutrophilic responses during HMPV infection. WT or KO
mice were infected with HMPV. At day 7 after infection, lung single-cell suspensions were
stained for neutrophils and lymphocyte populations (CD4+, CD8+ T cells). Means ± SEM are
shown; n = 4–15 mice/group. ***P < 0.001.
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3.4 Discussion
In this study, we investigated the role of γδ T cells during lung inflammatory response in
HMPV infection. With ablation of γδ TCR, we observed a change in IL-6, which from previous
studies, is known to regulate neutrophil trafficking [20]. Other studies have also shown that IL-6
signaling activates γδ T cells in airway inflammation [18]. Our study indicates that IL-6 levels
are altered in HMPV infection in the absence of γδ T cells (Fig. 3.1). Thus, these findings
complement our previous report, where we found that neutrophils regulate lung inflammatory
responses via recruitment of γδ T cells during human metapneumovirus infection [3]. Hence we
confirm that γδ T cells and neutrophils act interdependently during lung inflammatory response
to HMPV infection, which was previously shown with other models of infection.
Based on our previous findings, where it was demonstrated a major contribution of γδ T
cells in HMPV-induced lung inflammation [3], we further investigated the effect of γδ T cells in
other parameters of HMPV-induced pathogenesis. We assessed the viral replication in the
absence of γδ T cells. Experimental observations indicate that HMPV replication is marginally
increased at d 4 p.i. and no differences were observed between the animal groups at d 7 p.i.,
indicating that γδ T cells do not have a major role on HMPV replication and clearance.
γδ T cells are also known to play an important role in linking innate and adaptive immune
responses [24]. However, in our study we found that lack of γδ T cells did not have any effect on
CD4+ or CD8+ T cell recruitment in the lung following HMPV infection, suggesting regulatory
role of γδ T cells on innate but not adaptive responses. Overall, this study contributes to our
understanding of the role that γδ T cells play in lung inflammatory responses during HMPV
infection.
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CHAPTER 4
HUMAN METAPNEUMOVIRUS ATTACHMENT PROTEIN
CONTRIBUTES TO NEUTROPHIL RECRUITMENT INTO THE
AIRWAYS OF INFECTED MICE
4.1 Introduction
Human metapneumovirus (HMPV) is a single negative-stranded RNA, enveloped virus
classified in the Paramyxoviridae family. Its genome, of 13,335 nt, codes for nine different
proteins: the fusion (F), attachment (G), small hydrophobic (SH), nucleocapsid (N),
phosphoprotein (P), polymerase (L), matrix (M), and second matrix (M2-1, M2-2) [1]. HMPV
was first identified in 2001 from nasopharyngeal aspirates of hospitalized infants [2], and has
soon emerged to be a leading respiratory pathogen worldwide infecting infants, elders, and
immunocompromized individuals [3]. Epidemiological data indicate that this respiratory virus
represents a major respiratory pathogen worldwide. HMPV is responsible for 5 to 15% of
pediatric hospitalizations for respiratory tract infections [4,5,6,7]. Indeed, it is second only to
Respiratory Syncytial virus (RSV) infection in infants admitted with lower respiratory tract viral
infections causing mortality and morbidity [4,8,9,10]. In elderly adults aged ≥65 years old,
HMPV accounts for about 4.1% hospitalizations with respiratory tract infections, impacting
more severely those subjects with underlying conditions, such as cardiovascular diseases, organ
transplantation, or other hematologic malignancies [11,12,13,14]. One hallmark of HMPV
infection is that it is characterized by aggravated inflammatory responses leading to bronchiolitis
and pneumonia [8]. Currently there is no approved vaccine available to protect from HMPV
infection.‡Inflammatory outcomes during HMPV infection are mediated by virus-induced
cytopathology and the secretion of cytokines and chemokines [15,16]. Clinical evidence
This chapter has been published as: Cheemarla NR. and A. Guerrero-Plata. Human
Metapneumovirus Attachment Protein Contributes to Neutrophil Recruitment Into the Airways
of Infected Mice in Viruses, 2017, 9(10).
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indicates that HMPV induces neutrophil infiltration and associated mediators within the airways
of infants with bronchiolitis [17], providing evidence of the neutrophilic inflammatory response
in vivo and highlighting the importance of these cells as a potential target of therapeutic
intervention for treatment of bronchiolitis in infected children. The increased neutrophil
infiltration by HMPV in the airways has been reproduced in the mouse model of infection,
including in adult [18,19,20] and aged mice [21], where HMPV infection induces similar
neutrophil recruitment into the airways of both age groups of mice [21]. However, the role of
HMPV in regulating the recruitment of neutrophils to the lungs remains elusive. On the other
hand, the interferon (IFN) response appears to regulate the neutrophil infiltration in some viral
[22,23] and bacterial [24] infections, as well as in tumor bearing mice [25,26]. In that regard,
HMPV infection induces a robust production of type I interferon in infected mice [27,28], which
appears to be regulated by the expression of the HMPV attachment protein (G protein) [28,29].
Therefore, we reasoned that HMPV G protein contributes to the neutrophil recruitment into the
airways during HMPV infection through the IFN response. For that, we used an experimental
mouse model to quantify IFN-α production, neutrophil recruitment, and chemokine response to a
recombinant HMPV lacking the G protein. We found that the lack of the attachment protein
increased the production of IFN-α but decreased the production of neutrophil chemoattractants
and the recruitment of neutrophils to the alveolar spaces. These findings suggest a key role for
HMPV attachment (G) protein in contributing to the inflammatory responses in vivo.
4.2 Materials and methods
4.2.1 Virus Stocks
Recombinant HMPV lacking the attachment G protein (rHMPV-ΔG) and full-length
recombinant HMPV (rHMPV) were generated by reverse genetics, as we previously described
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[28]. The viruses were grown and titrated in LLC-MK2 cells (ATCC, Manassas, VA, USA) in
the presence of trypsin (Worthington, Lakewood, NJ, USA). Viruses were sucrose purified and
not used beyond passage 5. [28]. In some experiments, rHMPV was exposed for 10 min to UV
irradiation, as previously reported [30].
4.3.2 Ethic Statement
Animal care and use were conducted in accordance with the National Institutes of Health
and Louisiana State University institutional guidelines. The Louisiana State University Animal
Care and Use Committee specifically approved this study under the protocol number: 15-062 (15
October 2015). Mice were housed in a temperature-controlled room with proper darkness-light
cycles, fed with a regular diet, and maintained under the care of the Division of Laboratory
Animal Medicine facility, Louisiana State University, Baton Rouge, LA. The mice were
sacrificed by an intraperitoneal injection of ketamine and xylazine, and exsanguinated via the
femoral vessels.
4.2.3 Mice and Infection Protocol
BALB/c mice were purchased from Harlan Laboratories. Female 8- to 12-week-old mice
were used in all of the experiments. Mice were anesthetized with a combination of ketamine and
xylazine, and infected intranasally with 50µL of hMPV diluted in phosphate-buffered saline. A
final administration dose of 5 × 104 PFU/mouse was used for the recombinant virus infections.
Mock-infected mice received 50µL total volume of PBS.
4.2.4 Mouse Sample Collection
Mice were euthanized by intraperitoneal injection of ketamine and xylazine, and
exsanguinated via the femoral vessels, as previously described [20,28]. Bronchalveolar lavage
(BAL) samples were collected by flushing the lungs twice with 1 mL PBS and centrifuged 3500
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rpm for 5 min at 4 °C. Cell-free BAL supernatants were stored at −75 °C until further analysis.
For viral gene expression using qRT-PCR, lung tissue was snap frozen in liquid nitrogen and
stored at −75 °C until further analysis.
4.2.5 Differential Leukocyte Counts
Bronchalveolar lavage (BAL) fluid was used for differential leukocyte counts using
cytospin methods. Cytospin samples were subsequently prepared from BAL cells and dyed with
Wright-Giemsa staining and subjected to differential leucocyte counts under a light microscope.
A total of 200 cells per slide were counted. The total cell numbers were enumerated from BAL
cell counts obtained by trypan blue exclusion.
4.2.6 Detection of Cytokines and Chemokines
Levels of cytokines and chemokines in BAL fluid were determined with the Milliplex
MAPTM 32-Mouse-Plex cytokine detection system (Millipore, Billerica, MA, USA), according to
the manufacturer’s instructions. The panel included the following cytokines: IL-1α, IL-1β, IL-2,
IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL 10, IL-12 p40, IL-12 p70, IL-13, IL-15, IL-17, M-CSF, GCSF, GM-CSF, IFN-γ, TNF, CXCL1, CXCL2, CXCL5, CXCL9, CXCL10, CCL2, CCL3,
CCL4, CCL5, CCL11, LIF, and VEGF. The range of sensitivity of this assay is 3.2 to 10,000
pg/mL. Cell-free BAL supernatants were also tested for the production of type I (IFN-α)
interferon using ELISA tests according to the manufacturer’s instructions (PBL Assay Science,
Piscataway, NJ, USA).
4.2.7 Real-Time qRT-PCR
Lung tissue stored at −75 °C was used for viral gene expression using qRT-PCR, as
described previously [13]. Briefly, RNA was extracted from the lung tissue using RNeasy Plus
kit (Qiagen, Hilden, Genmany) and viral gene expression was determined using specific primers
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and probes (Integrated DNA Technologies, Coralville, IA, USA) on a 7900HT Fast Real-Time
PCR following manufacturer’s instructions. Expression of target genes was quantified using the
comparative cycle threshold method and results were normalized to the endogenous GAPDH
with expression levels normalized to transcripts from mock-infected mice.
4.2.8 Statistical Analysis
Statistical significance was calculated by unpaired t test and one-way ANOVA to
ascertain the differences between the animal groups, followed by a Tukey-Kramer test to correct
for multiple comparisons using Graph Pad InStat 3 (GraphPad Software, La Jolla, CA, USA).
4.3 Results
4.3.1 Inhibition of IFN-α Responses by HMPV G Protein In Vivo
Previous studies in vitro have identified HMPV G protein as a negative regulator of the
IFN response [28,29]. In order to determine the effect of the HMPV G protein in the IFN
response in vivo, BALB/c mice were infected with rHMPV, rHMPV-∆G or mock infected. After
24 h of infection, BAL supernatants were collected and tested for the IFN production by ELISA.
As shown in Figure 4.1a, the lack of the attachment glycoprotein resulted in a significant
increase in the production of IFN-α. We observed that mice infected with rHMPV-ΔG induced a
1.3-fold increase in the production of IFN-α as compared to full-length rHMPV infected mice.
However, no difference in viral gene expression was noted when compared between rHMPV and
rHMPV-∆G after 24 h of infection (Figure 4.1b), confirming that the infection of mice with
rHMPV and rHMPV-∆G was comparable. Thus, validating the inhibitory effect of G protein on
the IFN response. Furthermore, in order to confirm that the observed production of IFN-α by
rHMPV was due to the viral infection, a group of mice were inoculated with UV-inactivated
rHMPV and the production of IFN was determined. Our data show that the inoculation of mice
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with UV-inactivated rHMPV failed to induce any production of IFN-α showing that IFN-α
production was dependent on the rHMPV replication (Figure 4.1a). Together, these results
demonstrate that HMPV-G protein regulates IFN-α responses in vivo.

Figure 4.1. Human Metapneumovirus (HMPV) G protein regulates interferon responses in vivo.
(a) BALB/c mice were infected with rHMPV-ΔG or rHMPV and Bronchalveolar lavage (BAL)
collected at day 1 after infection. Interferon-α (IFN-α) responses were determined by ELISA in
BAL collected at day 1 after infection; (b) HMPV viral gene expression in infected mice.
BALB/c mice were infected with rHMPV-ΔG or rHMPV and lung tissue collected at day 1 after
infection. Expression of HMPV N was done by qRT-PCR. n = 4–10 mice/group. Mean ± SEM
are shown. ** p < 0.01, *** p < 0.005.
4.3.2 HMPV G Protein Contributes to Neutrophil Recruitment
To determine whether the HMPV attachment glycoprotein plays a role in the recruitment
of neutrophils, BAL samples were collected 24 h after inoculating mice with rHMPV, rHMPV∆G or PBS, and differential cell analysis was performed. We focused on the neutrophil
recruitment at 24 h based on previous observations that indicate that neutrophil recruitment
peaks at day 1 after HMPV infection [20]. As shown in Figure 4.2a, analyses of cytospin
preparations revealed a significant decrease in the total number of neutrophils recruited to
alveolar spaces in mice infected with rHMPV-ΔG (1.0 × 105 ± 0.2) when compared with those
with rHMPV infection (3.1 × 105 ± 0.3), indicating that G protein contributes to the recruitment
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of neutrophils. Also, the levels of recruitment of neutrophils in rHMPV-ΔG (1.0 × 105 ± 0.2)
were comparable to mice infected with UV light inactivated rHMPV (0.8 × 105 ± 0.3). On the
other hand, there was no evident change in the recruitment of monocytes/macrophages (Figure
4.2c) or lymphocyte population (Figure 4.2b), suggesting that G protein contributes mainly to the
recruitment of neutrophils to the alveolar spaces.

Figure 4.2. HMPV G protein contributes to neutrophil infiltration into the airways of infected
mice. BALB/c mice were infected with rHMPV-ΔG or rHMPV and BAL collected at day 1 after
infection. Total number of (a) neutrophils; (b) lymphocytes and (c) monocytes/macrophages was
determined by cytospin analysis and total number of cells enumerated by total BAL cell
counts. n = 4–10 mice/group. Mean ± SEM are shown. *** p < 0.005.
4.3.3 HMPV G Regulates Lung Cytokine and Chemokine Profile in the Lungs of Infected Mice
To further elucidate the role of G protein in the production of neutrophil chemoattractants
and proinflammatory cytokines, we sought to assess the production of lung cytokine and
chemokine profile after 24 h of rHMPV-ΔG infection and compare it to that of rHMPV. Cellfree supernatants from BAL samples were analyzed by multiplex assay, using multi-Plex
cytokine detection, as described in methods. As shown in Figure 4.3, the levels of TNF (↓58%),
IL-17(↓44%), CXCL2(↓40%), VEGF (↓46%), CCL3(↓54%), and CCL4 (↓68%), were decreased
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(as indicated) in mice infected with rHMPV-ΔG as compared with those infected with full-length
rHMPV, suggesting that G protein contributes to the production of these chemokines in vivo.
However, when compared between both groups of infected animals, no significant difference
was observed in the production of IL-1α, IL-1β, IL-4, IL-5, IL-6, IL-9, IL 10, IL-12 p70, IL-13,
IL-15, M-CSF, G-CSF, GM-CSF, IFN-γ, CXCL1, CXCL5, CXCL9, CXCL10, CCL2, CCL5,
CCL11, and LIF. Other cytokines were not induced by the recombinant viruses in the infected
mice (IL-2, IL-3, IL-7, and IL-12 p40).

Figure 4.3. HMPV G alters cytokine profile in infected mice. BALB/c mice were infected with
rHMPV-ΔG or rHMPV and BAL collected next day. BAL samples from each group of mice
were assessed for cytokine/chemokine production by a multi-Plex cytokine detection system. n =
4–10 mice/group. Mean ± SEM are shown. * p < 0.05, ** p < 0.01, *** p < 0.005.
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4.4 Discussion
The regulation of the inflammatory immune response by infectious agents involves
several factors from the host and the pathogen. Viral infections are known to alter the innate
immune response [31,32]. In fact, several viral proteins are known to inhibit the IFN response in
vitro [29,33,34] and in vivo [35]. In that regard, despite previous studies have demonstrated that
the attachment glycoprotein (G) of HMPV inhibits the IFN response in vitro [28,29], this work
demonstrates, for the first time, that the HMPV G protein inhibits the IFN response in vivo. Due
to the restriction of high viral titers of the purified recombinant viruses, the final administered
viral inoculum was 5 × 104 PFU/mouse. However, that amount of viral inoculum was enough to
induce an IFN-α response that allowed us to define the inhibitory effect of the HMPV G protein
in vivo. That inhibitory effect was validated by the fact that both viral inoculums (rHMPV and
rHMPV-∆G) were comparable as they were purified and titrated by the same methods, and no
difference was observed in the viral gene expression when measured in the lung samples from
the infected mice (Figure 4.1b).
There is evidence that interferons have pleiotropic immune functions in several models.
In an experimental mouse model, type I IFN suppresses neutrophil recruitment by negatively
regulating CXC chemokine expression in influenza [23,36], herpes simplex-1 [22], Listeria
monocytogenes [24], and tumor-associated diseases [26]. Thus, the observed increased
production of IFN-α by rHMPV-ΔG, due to its regulatory effect [22,37], may contribute to the
suppression of the recruitment of neutrophils induced by HMPV. On this subject, several studies
indicate that neutrophils are the predominant cell population recruited to the alveolar spaces in
HMPV-infected mice during the early phase of the infection (Figure 4.2 and [18,19,20]).
However, to the best of our knowledge, these findings represent the first evidence that the
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HMPV attachment protein contributes to the recruitment of neutrophils into the lungs. Moreover,
the UV treatment of rHMPV significantly reduced the number of neutrophils, indicating that the
recruitment of these cells is dependent on viral replication and the de novo synthesis of the G
protein. These observations are in line with studies with other respiratory viruses, including those
with respiratory syncytial virus (RSV), an HMPV-close-related human paramyxovirus, in which
it has been shown that the fusion (F) protein, of the RSV 2–20 strain, contributes to the
infiltration of neutrophils into the lungs of infected mice [38]. Similarly, influenza A virus, a
ssRNA ortomyxovirus, appears to regulate neutrophil infiltration into the alveolar spaces through
the expression of the PB1-F2 protein [39]. This suggests that different surface viral proteins can
specifically contribute to the infiltration of neutrophils to the respiratory tract.
The observed contribution of the HMPV G protein to the recruitment of neutrophils in the
infected mice, suggest that G protein may also regulate the expression of those cytokines and/or
chemokines that control the recruitment of neutrophils to the alveolar spaces. Opposite to the
effect of HMPV G protein on the IFN response, we observed some changes in CCL3, CCL4,
VEGF, TNF, IL17, and CXCL2, which are all recognized mediators involved in the neutrophil
recruitment to the sites of insult. In this work, we observed that the lack of G protein in HMPV
resulted in the reduced expression of TNF and IL-17, which are known to promote the
expression of neutrophil chemotactic cytokines. In fact, IL-17 together with TNF can
synergistically induce the endothelial expression of neutrophilic chemokines including CXCL2
[40], which may explain also the reduced expression of CXCL2 observed in the rHMPV-ΔGinfected mice. In addition, we speculate that due to its suppressive effect on TNF [41], the IFN-α
response in rHMPV-ΔG could be linked to the reduced production of TNF. In the same context,
IFN-α has been reported to inhibit IL-17 production in PBMC’s from patients with chronic
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active Hepatitis B infection (CAHB), suggesting the pleiotropic effect IFN-α has on
proinflammatory cytokines associated with neutrophil activation and chemotaxis [42]. Moreover,
type I IFN has also been shown to repress CXCL2 production in in vivo [23] and in vitro [36]
settings, suggesting that the increased IFN-α response in rHMPV-ΔG could contribute to the
observed diminished production of CXCL2. Furthermore, the absence of G protein led to a
decrease in the expression of VEGF, which could also impact the neutrophil numbers to the site
of infection since VEGF contributes to the recruitment of proangiogenic neutrophils from the
circulation to the tissues [43]. These results are in line with data from melanoma studies in vitro,
where IFN-α treatment significantly reduced the expression of VEGF suggesting a suppressive
effect of Type I IFN on this cytokine [44,45]. Finally, the neutrophil recruitment after rHMPVΔG infection could have also been altered by the reduced expression of CCL3 and CCL4, which
are neutrophil-active chemokines [46]. However, studies in vitro in an epithelial cell line (A549)
indicate that the HMPV G protein rather inhibited the expression of CCL3 and some other
cytokines [29]. This discrepancy might be due not only to the inherent differences of the
experimental models, but also to the exerted effect of HMPV G protein on the complex
microenvironment in vivo, where several cellular populations, including macrophages,
lymphocytes, endothelial, and epithelial cells, mediate the overall cytokine/chemokine
production. In fact, similar observations to the current work have been reported in a mouse
model of pneumonia virus, where the nonstructural (NS) proteins NS1 and NS2 (rPVM
∆NS1∆NS2; rPVM ∆NS2) antagonize IFN responses in vivo, but on the other hand, induced
lower amounts of proinflammatory cytokines in the airways when compared to rPVM virus [35].
However, data on viral proteins regulating neutrophilic responses to the sites of inflammation is
limited and further work is warranted. Overall, data from this work suggest that the attachment
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protein of HMPV regulates neutrophil recruitment to the lungs by modulating the production of
neutrophil chemoattractants.
In summary, the above results demonstrate a novel role for the attachment protein of
HMPV as a contributing factor for neutrophil recruitment to the sites of infection. This effect
appears to be influenced by the regulation of neutrophil chemoattractants and an exacerbated
response of type I IFN production. We have recently demonstrated that neutrophils exert a
protective effect to HMPV-induced pathogenesis in mice [20]. However, an exacerbated
accumulation of neutrophils contribute to severe pulmonary inflammation [17]. Therefore, a
controlled balance of neutrophil accumulation in the airways after HMPV infection would be
helpful for the outcome of the infected individuals. In this regard, the attachment protein of
HMPV represents an attractive target for future therapeutic applications to reduce an excessive
accumulation of neutrophils in the airways.
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CHAPTER 5
HOW DOES THE HUMAN METAPNEUMOVIRUS REGULATE
NEUTROPHIL INFILTRATION INTO THE AIRWAYS?
5.1. Summary
Since its discovery in 2001, human metapneumovirus (HMPV) has been recognized as a
respiratory pathogen of clinical significance that infects children, the elderly and
immunocompromised patients [1,2]. Infection by this virus is characterized by acute lower
respiratory tract infection and symptoms range from common cold-like syndrome to more severe
manifestations such as bronchiolitis and pneumonia, which require hospitalization. Thus, HMPV
can cause severe pulmonary inflammation. Recent clinical evidence indicates that neutrophil
infiltration is induced within the airways of children with HMPV-induced bronchiolitis [3]. This
phenomenon has been reproduced in experimental mouse models of infection by several
groups [4–7]. However, limited information has been reported regarding the interaction between
HMPV and neutrophils in the lungs of infected mice.
In understanding that interaction, we have previously demonstrated that depletion of
neutrophils led to an in-creased disease severity and lung inflammation, indicating a protective
role of these cells during HMPV infection [4]. Furthermore, we have also explored the
mechanisms by which HMPV infection contributes to the recruitment of neutrophils in the lung.
In this context, we have investigated the role of HMPV attachment protein in contributing to the
recruitment of neutrophils into the airways [8]. The attachment glycoprotein (G) of HMPV is one
of the three putative membrane proteins expressed by the virus. Though, the attributed function§
for the attachment protein is to aid in the attachment of the virus to the target cells, several
This chapter has been published as: Cheemarla NR. and A. Guerrero-Plata. How Does the
Human Metapneumovirus Regulate Neutrophil Infiltration Into the Airways? in Future Virology,
2018, Epub ahead of print.
81

studies have demonstrated that cell attachment and fusion can happen in the absence of HMPVG protein [9,10]. Apart from its roles in viral infection, the G protein is also known to modulate
several aspects of the innate immune response [11–13]. However, the contribution of this protein
in pulmonary inflammatory responses during HMPV infection remains poorly understood.
Therefore, we speculated on two previous findings in which it was indicated that
interferon has a regulatory effect on neutrophil recruitment [14–17], and that G protein of HMPV
suppresses interferon responses, as we and other groups have previously reported [11,13]. Based
on those observations, we hypothesized that the viral G regulates neutrophil infiltration in
HMPV-infected animals. In order to test that, we used a recombinant virus lacking the G protein
(rHMPV- G), as described previously [11], and infected BALB/c mice intranasally with rHMPVG or with the full-length recombinant HMPV (rHMPV), as a reference control. Recruitment of
neutrophils into the airways was quantified by differential cell counts, and the production of
interferon and additional cytokines was measured by ELISA and multiplex cytokine detection
assays, respectively. Analysis of the interferon production by the rHMPV- G in BALB/c mice
indicated that the absence of the attachment protein increased the levels of IFN-α in the lungs of
the infected mice. Furthermore, those mice infected with the rHMPV- G showed decreased
neutrophil infiltration into the airways compared with the ones infected with the rHMPV, but did
not have an effect on macrophages or lymphocytes, indicating that the G protein was found to
have a specific effect on neutrophils. Those findings led us to explore the effect of G protein on
additional cytokines/chemokines. We observed that the absence of G protein also decreased the
lung cytokine/chemokine profile such as TNF-α, VEGF, IL-17, CCL3, CCL4 and CXCL2, all
known to have a chemotactic effect on neutrophils and to contribute to the recruitment of these
cells to the site of infection. Overall, these findings demonstrate that the attachment protein of
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HMPV contributes to the recruitment of neutrophils during the viral infection. This happens
potentially through a mechanism that involves the inhibition of interferon responses by the
HMPV-G protein, which in turn would allow the induction of high levels of neutrophilchemotactic cytokines, and consequently higher numbers of neutrophils present in the airways of
the infected animals. Whether other HMPV proteins could also play a role in the neutrophil
recruitment is unknown. But it is likely that proteins that modulate the interferon response could
have an effect on neutrophilic chemokines, based on the effect of interferon on neutrophil
responses [14–17]. In conclusion, our study highlights the important role of viral proteins in
neutrophil recruitment, which is not trivial, given the critical contribution neutrophils have in the
inflammatory outcome of HMPV-infected individuals [3]. That is, excessive recruitment of these
cells during the infection can have a negative outcome, leading to exacerbated inflammatory
responses, so their recruitment during HMPV needs to be regulated. In this context, our work
demonstrates the contribution of the viral attachment protein to the recruitment of these cells into
the airways. On the other hand, we have also reported that the absence of neutrophils leads to an
increased inflammatory response during HMPV infection, mediated by γδ T cells [4]. Thus, upon
HMPV infection, a fine balance of neutrophil response is necessary for an optimal activation of
the immune system and controlled inflammatory response. Hence, these findings help further our
understanding of the complex interplay between the beneficial and detrimental roles of
neutrophils in the inflammatory responses during HMPV infection.
5.2 References
1. Schildgen V, Van Den Hoogen B, Fouchier R et al. Human metapneumovirus: lessons
learned over the first decade. Clin. Microbiol.Rev. 24(4), 734–754 (2011).
2. Van Den Hoogen BG, De Jong JC, Groen J et al. A newly discovered human pneumovirus
isolated from young children with respiratory tract disease. Nat. Med. 7(6), 719–724 (2001).
83

3. Cavallaro EC, Liang KK, Lawrence MD, Forsyth KD, Dixon DL. Neutrophil infiltration and
activation in bronchiolitic airways are independent of viral etiology. Pediatr.
Pulmonol. 52(2), 238–246 (2017).
4. Cheemarla NR, Banos-Lara MDR, Naidu S, Guerrero-Plata A. Neutrophils regulate the lung
inflammatory response via gammadelta T cell infiltration in an experimental mouse model of
human metapneumovirus infection. J. Leukoc. Biol. 101(6), 1383–1392 (2017).
5. Kolli D, Bataki EL, Spetch L et al. T lymphocytes contribute to antiviral immunity and
pathogenesis in experimental human metapneumovirus infection. J. Virol. 82(17), 8560–
8569 (2008).
6. Hamelin ME, Yim K, Kuhn KH et al. Pathogenesis of human metapneumovirus lung
infection in BALB/c mice and cotton rats. J.Virol.79(14), 8894–8903 (2005).
7. Darniot M, Pitoiset C, Petrella T, Aho S, Pothier P, Manoha C. Age-associated aggravation
of clinical disease after primary metapneumovirus infection of BALB/c mice. J. Virol. 83(7),
3323–3332 (2009).
8. Cheemarla NR, Guerrero-Plata A. Human metapneumovirus attachment protein contributes
to neutrophil recruitment into the airways of infected mice. Viruses 9(10), pii:E310 (2017).
9. Biacchesi S, Skiadopoulos MH, Yang L et al. Recombinant human metapneumovirus lacking
the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a
promising vaccine candidate. J. Virol. 78(23), 12877–12887 (2004).
10. Schowalter RM, Smith SE, Dutch RE. Characterization of human metapneumovirus F
protein-promoted membrane fusion: critical roles for proteolytic processing and low pH. J.
Virol. 80(22), 10931–10941 (2006).
11. Banos-Lara Mdel R, Harvey L, Mendoza A et al. Impact and regulation of lambda interferon
response in human metapneumovirus infection. J. Virol. 89(1), 730–742 (2015).
12. Kolli D, Bao X, Liu T et al. Human metapneumovirus glycoprotein G inhibits TLR4dependent signaling in monocyte-derived dendritic cells. J. Immunol. 187(1), 47–54 (2011).
13. Bao X, Liu T, Shan Y, Li K, Garofalo RP, Casola A. Human metapneumovirus glycoprotein
G inhibits innate immune responses. PLoSPathog. 4(5), e1000077 (2008).
14. Stock AT, Smith JM, Carbone FR. Type I IFN suppresses Cxcr2 driven neutrophil
recruitment into the sensory ganglia during viral infection. J. Exp. Med. 211(5), 751–759
(2014).
15. Seo SU, Kwon HJ, Ko HJ et al. Type I interferon signaling regulates Ly6C(hi) monocytes
and neutrophils during acute viral pneumonia in mice. PLoS Pathog. 7(2), e1001304 (2011).
84

16. Brzoza-Lewis KL, Hoth JJ, Hiltbold EM. Type I interferon signaling regulates the
composition of inflammatory infiltrates upon infection with Listeria monocytogenes. Cell
Immunol. 273(1), 41–51 (2012).
17. Andzinski L, Kasnitz N, Stahnke S et al. Type I IFNs induce anti-tumor polarization of
tumor associated neutrophils in mice and human. Int. J. Cancer 138(8), 1982–1993 (2016).

85

CHAPTER 6
PRENATAL SMOKE EXPOSURE EXACERBATES LUNG
INFLAMMATORY RESPONSE BY MODULATING NEUTROPHIL
INFILTRATION TO THE LUNGS AFTER RSV INFECTION
6.1 Introduction
Tobacco smoke exposure is considered a worldwide problem and an important cause of
morbidity and mortality in active as well as passive smokers. In particular, parental smoking
during pregnancy has been associated with a range of adverse health effects in both smoking
parents as well as in offspring. These adversities include but are not limited to COPD, asthma
exacerbation, increased frequency of lower respiratory tract infections, cardiovascular diseases,
cancer predisposition and otitis media [1-6]. In understanding the underlying mechanism behind
these adversities, several constituents of tobacco smoke, known to have immunomodulatory
effects have been shown to cross the placenta, thus affecting the development of immune system
of the fetus in-utero [7]. Therefore, it is evident that in-utero exposure to second hand smoke
(SHS) results in alteration of host immune responses in the offspring [8, 9].
Despite these finite evidences on how in-utero exposure predisposes offspring to altered
immunity, there is limited to no evidence on the effect of SHS on host responses during lower
respiratory tract infections, particularly respiratory viral infections. Epidemiological studies
show that prenatal tobacco smoke exposure via active and passive maternal smoking leads to
increased severity of bronchiolitis in infants [10]. One such leading cause of bronchiolitis in
infants is infection with respiratory syncytial virus (RSV), a negative sense, single-stranded RNA
pneumovirus causing acute lower respiratory tract infection. Findings from previous studies
indicate that in RSV associated bronchiolitis in infants, neutrophils are the predominant cell
population recruited to the airways after infection [15,16, 21]. Thus it is evident that neutrophils
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play a crucial role in RSV induced inflammatory responses and contributing to bronchiolitis.
Also, recent studies emphasize more on a potential link between cigarette smoke, neutrophils and
associated inflammation [11-14]. Nevertheless, the mechanism behind SHS induced immune
exacerbations during RSV infection has not been documented. In understanding this aspect, we
sought to investigate the effect of in-utero SHS exposure on RSV induced inflammatory
exacerbations in the neonatal murine lung.
In the work here, we demonstrate using a neonatal mouse model of in-utero smoke
exposure, the effect of cigarette smoke on lung inflammation and neutrophil response after RSV
infection. Our findings indicate that in-utero SHS exposure exacerbated lung inflammation upon
RSV infection, which is mediated by increased infiltration of neutrophils into inflamed airways.
Furthermore, neutrophils from SHS exposed and RSV infected neonates were highly activated,
as indicated by increased CXCR2 expression. Overall, our work demonstrates that in-utero SHS
exposure modulates lung inflammatory responses during RSV infection in neonatal mice.
6.2 Materials and Methods
6.2.1 Virus
RSV strain A2 (American Type Culture Collection, Manassas, VA) was grown and titrated in
Hep2 cells (ATCC) as described previously [17].
6.2.2 Mice and smoke exposure
Eight- to 10-wk-old BALB/c mice were purchased from Envigo (Indianapolis, IN, USA). All
mice were housed in specific pathogen-free conditions in accordance with the Louisiana State
University Institutional Animal Care and Use Committee. For smoke exposure, BALB/c mice
were acclimatized to tobacco smoke for 2 weeks prior to mating. The experimental study design
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is presented in Fig. 6.1. Briefly, male and female mice were exposed to 100% mainstream smoke
using Scireq inExpose system (Montreal, QC, CA). Mice were exposed to 4- 3R4F filtered
research cigarettes (University of Kentucky, Lexington, KY) with 30-minute gap between each
cigarette for 5 days a week. Once pregnant, only female BALB/c mice were exposed to
mainstream smoke until delivery. Pups from unexposed mice were considered as air exposed
mice.
6.2.3 Infections
Neonatal mice (5 days old) were infected with 5 x 105 PFU of RSV in 10µl total volume via the
i.n. route. Mock-infected animals received 10µl sterile PBS (herein, referred to as mock).
6.2.4 Histopathology analysis of lungs
The lungs of the mice were inflated with buffered formalin phosphate (10%) by intratracheal
instillation. Wax embedded tissues were used to prepare 5-µm thick lung sections and stained
with Hematoxylin & Eosin. Stained slides were visualized by bright-field microscopy using the
highthroughput slide-scanner NanoZoomer and the NanoZoomer digital pathology view software
(both from Hamamatsu Photonics, Hamamatsu City, Japan), as previously reported [18].
Additional lung sections were PAS stained to assess goblet cell hyperplasia and calculate mucus
index. PAS stained slides were visualized same as H&E slides using NanoZoomer and the
NanoZoomer digital pathology view software. Mucus index was calculated as the area of PAS
positive airway epithelium/total area of the conducting airway epithelium.
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6.2.5 Bronchoalveolar lavage cell and fluid collection
As previously described [18], following euthanasia, we lavaged the lungs of each mouse 2 times
with 150 µL phosphate-buffered saline (PBS). The BAL was centrifuged at 14000 rpm for 1 min
and supernatant was stored at −70 °C for subsequent analyses.
6.2.6 Detection of Cytokines and Chemokines
Cytokine and chemokine release in cell-free BAL supernatants was determined using the
Milliplex MAPTM 32-Mouse-Plex cytokine detection system (Millipore, Billerica, MA, USA),
according to the manufacturer’s instructions. The assay panel included the following cytokines
and chemokines: IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL 10, IL-12 p40, IL-12
p70, IL-13, IL-15, IL-17, M-CSF, G-CSF, GM-CSF, IFN-γ, TNF, CXCL1, CXCL2, CXCL5,
CXCL9, CXCL10, CCL2, CCL3, CCL4, CCL5, CCL11, LIF, and VEGF. The range of
sensitivity of the assay is 3.2 to 10,000 pg/ml.
6.2.7 Flow cytometry
For flow cytometry staining, lung single-cell suspensions were obtained as described previously
[19]. Briefly, cells were incubated with anti-CD16/CD32 (Clone 2.G2) antibody at 4°C for 30
min. Cells were then washed with 1X PBS/1% BSA and stained with anti-Ly6G (Clone RB68C5), anti-CD11b (Clone M1/70) for 30 min at 4°C (BD Pharmingen, San Jose, CA, USA).
After the incubation, cell were washed with PBS/1% BSA and fixed with 1% paraformaldehyde.
Cells were run on FACScan flow cytometer (BD Biosciences, San Jose, CA, USA) and data
analyzed using FlowJo software (version 10; Tree Star, Ashland, OR, USA).

89

6.2.8 Statistical Analysis
Statistical significance was calculated by one-way ANOVA to ascertain the differences between
3 or more animal groups, followed by a Tukey-Kramer test to correct for multiple comparisons.
For comparison of 2 groups, a student’s t-test was used (two-tailed, two-sample equal variance.
All analyses were performed using Graph Pad InStat 3 (GraphPad Software, La Jolla, CA, USA).
P ≤ 0.05 was considered statistically significant and unless otherwise indicated, results are
expressed as mean ± SEM.

Figure 6.1. In-utero cigarette smoke exposure model representation.
6.3 Results
6.3.1 RSV infection exacerbates lung inflammation in secondhand smoke exposed neonatal mice
To define the role of maternal smoke induced immune exacerbation in offspring, we infected
secondhand smoke exposed or unexposed day 5 neonates with RSV or Control (PBS) for 7 days.
At day 7 after infection, lungs were collected, and tissue sections were processed for lung
pathological evaluation (Fig. 6.2A). Lung histopathological analysis revealed that mice that were
unexposed or exposed to second hand smoke (SHS) show minimal to no airway inflammation.
However, after RSV infection, unexposed mice showed an increased pathology score, and the
lung inflammation for RSV-infected mice after SHS exposure was significantly higher when
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compared to the RSV-infected unexposed group, suggesting an exacerbated airway inflammation
by the effect of smoke in the RSV-infected animals (Fig 6.2B).

Figure 6.2. RSV infection after second hand smoke (SHS) exposure exacerbates lung
inflammation. In-utero smoke exposed or unexposed neonatal mice were infected with 5x105
PFU of RSV. At day 7 after infection, lungs were perfused and fixed in 10% buffered formalin
and embedded in paraffin. Multiple 4µm-thick sections were stained with haemotoxylin & eosin
(H&E) to assess lung inflammation (Magnification: 40X). n= 4-10 mice. Control mice were
mock infected with PBS. Mean ± SEM are shown. **P<0.01, ***P<0.005.
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6.3.2 RSV infection after in-utero smoke exposure alters lung cytokine/chemokine profile
In further delineating the exacerbated inflammatory responses observed in SHS exposed and
RSV-infected neonates, the concentration of cytokines and chemokines were measured. For this,
neonatal mice that were SHS exposed or unexposed were infected i.n. with RSV or PBS, and
BAL samples were obtained from each group at d 7 after infection (when the inflammatory
response was determined). The level of cytokines and chemokines in BAL were measured using
a multiplex cytokine detection system. As shown in Figure 6.3, we found that SHS exposure led
to an increased response of inflammatory and immunoregulatory cytokines after RSV infection.
We observed a 2-fold increase in KC (CXCL1, a potent neutrophil chemokine), in SHS RSVinfected group compared to RSV infected alone mice. On the other hand, other cytokines and
chemokines were altered with no significant differences between the different experimental
groups.
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Figure 6.3. Lung cytokine/chemokine profile in RSV infected and SHS exposed neonatal
mice. In-utero smoke exposed or unexposed neonatal mice were infected with 5x105 PFU of
RSV. BAL collected at day 7 after infection was used for cytokine/chemokine Mean ± SEM is
shown. n= 5-12 mice. Control mice were mock infected with PBS and smoke or air exposed.
Mean ± SEM are shown. **P≤0.05.
6.3.3 Secondhand smoke exposure increases neutrophil influx into the airways of RSV infected
neonates.
Based on the cytokine and chemokine profile assayed in Figure. 6.2, we sought to characterize
the cell subsets infiltrated in the lungs. We focused on the recruitment of neutrophils since
CXCL1 recruits and activates these cells. For that, lungs were harvested at the peak of
inflammation (d 7 p.i.). Lung single-cell suspensions were prepared from mock-infected, SHS
exposed, RSV infected or SHS RSV infected mice. The infiltration of neutrophils was assessed
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by flow cytometry analysis by staining the lung single-cell suspensions for CD 11b and Ly6G
(Fig. 6.4A-B). Data shown in figure 6.4 indicates that SHS exposure followed by RSV infection
led to an increased influx of neutrophils into the lungs during peak inflammation (d 7 p.i.). We
found that SHS exposure significantly increased the recruitment of neutrophils after RSV
infection, both percentage (Fig. 6.4A) and numbers (13± 2 x 105 cells) (Fig. 4B), compared with
mice that were RSV infected alone (7.5± 1 x105 cells), mock-infected (6.5± 1 x105 cells), or SHS
exposed (9± 0.5 x105 cells). These findings strongly suggest that neutrophils are key players in
exacerbated lung inflammation in these mice.
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Figure 6.4. RSV infection in SHS exposure induces neutrophil influx into the lungs. In-utero
smoke exposed or unexposed neonatal mice were infected with 5x105 PFU of RSV. At day 7
after infection, lungs cells were stained with specific antibodies and analyzed using flow
cytometry to measure neutrophil responses. A) Neutrophil gating strategy. B) Total neutrophil
counts from FACS analysis. n= 4-10 mice. Control mice were mock infected with PBS. Mean ±
SEM are shown. **P≤0.05, ***P<0.005.
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6.3.4 Neutrophils from SHS and SHS+RSV infected neonates are highly activated.
Given that neutrophils are recruited by increased CXCL1, we then wanted to see if CXCR2 is the
target receptor on neutrophils for CXCL1 mediated activation. Recent studies have also shown
that CXCL1 mediated neutrophil trafficking in the lungs is via CXCR2 activation. For
confirming this, we characterized the neutrophils in SHS + RSV mice lungs and screened them
for CXCR2 up-regulation (Fig. 6.5A). Flow staining for neutrophils revealed that CXCR2 was
indeed up-regulated in lung neutrophils from neonatal mice that were SHS exposed and
SHS+RSV infected compared to the mock infected or RSV infection alone (Fig. 6.5B).
Interestingly, when we measured CXCR2 activation on lung neutrophils in mock-infected, SHS
exposed, RSV infected or SHS exposed with RSV infection, we found that both SHS exposure
alone (mean-21.48) and SHS exposed with RSV infection (mean-20.54) showed a robust
increase in CXCR2 activation compared to RSV infected alone (mean-10.97) neutrophils
suggesting the role of SHS in inducing neutrophil activation (Fig. 6.5B).
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Figure 6.5. SHS exposure highly activates infiltrated neutrophils. In-utero smoke exposed or
unexposed neonatal mice were infected with 5x105 PFU of RSV. At day 7 post infection, lungs
cells were stained with specific antibodies and analyzed using flow cytometry to measure
CXCR2 expression on neutrophils. A) CXCR2 expression analysis. B) Mean fluorescent
intensity of neutrophil CXCR2 expression from FACS analysis. n= 4-10 mice. Control mice
were mock infected with PBS. Mean ± SEM are shown. **P≤0.05.
6.4 Discussion
Based on reported evidences, it is evident that cigarette smoke alters host responses in active as
well as passive smokers [8,9]. Furthermore, emerging data also support that maternal smoking
during pregnancy also has an impact on developing immune system in the offspring. In fact,
several constituents of tobacco smoke are known to cross the placenta and modulate the
developing immune system in the fetus [7]. These alterations have an impact on immune
outcomes during external insults. Nevertheless, knowledge on how secondhand smoke exposure
alters immune outcomes during an external stimulus is not clear. One such insult known to be a
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leading cause of morbidity and mortality in infants worldwide is respiratory syncytial virus
infection, causing acute lower respiratory tract infection and associated bronchiolitis.
Therefore, our studies were designed to address the effect of in-utero smoke exposure on
inflammatory responses in the airways during RSV infection. The key aspect we wanted to
investigate is whether SHS exposure alters lung inflammatory response during RSV infection. If
so, we wanted to identify the mechanism leading to this inflammatory exacerbation. RSV
infection in mice leads to increased lung inflammation on day 7 after infection as indicated by
high pathology score and release of associated mediators into the airways. So, to determine if
SHS exposure and subsequent RSV infection have any effect on lung inflammation, we assessed
lung pathology at day 7 after infection in both SHS as well as unexposed mice infected with
RSV or mock infected. As shown in Figure 6.2, RSV infection in SHS exposed neonatal mice
led to increased lung inflammation as indicated by pathology score compared to RSV infection
alone or SHS alone. These findings demonstrated that in-utero smoke exposure alters lung
immune responses and thus leads to exacerbated inflammation during RSV infection. Hence we
further investigated the mechanism behind exacerbated lung inflammation observed in SHS
neonates infected with RSV.
In further understanding the potential mechanism of the recruitment of neutrophils in RSV SHSexposed mice, we assessed lung cytokine and chemokine profile, which would give us a sense of
the immune cells recruited causing lung inflammation. We observed that, RSV infection in SHS
exposed neonatal mice significantly increased the production of CXCL1 in the bronchoalveolar
spaces. CXCL1 is a known potential neutrophil chemo-attractant produced mainly by epithelial
cells, macrophages, γδ T cells and neutrophils and it aids in the infiltration of neutrophils from
circulation to sites of insult. Therefore, this finding led us to speculate that neutrophils are the
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one causing exacerbated lung inflammation in SHS neonates infected with RSV. As we
speculated, SHS mice infected with RSV had a significant increase in the influx of neutrophils
into the airways compared to RSV infection alone or SHS exposure alone. From our previous
findings, we have shown that neutrophils when depleted during HMPV infection, a virus
belonging to the same family as RSV, leads to altered immunity showing the beneficial role of
neutrophils [18]. However, excessive recruitment of these cells to the site of infection has been
shown to cause tissue damage and inflammation. Thus, a balance of these cells is necessary to
impart beneficial immune response. Furthermore, we also observed that the neutrophils from
SHS or SHS mice infected with RSV were highly activated as indicated by increased expression
of CXCR2, a receptor expressed by neutrophils and binds ligands CXCL1/2. This effect was
earlier demonstrated in adult mice exposed to mainstream cigarette smoke, wherein smoke
exposure induced CXCL1 production and CXCR2 expression on neutrophils. Treatment with
CXCR2 antagonists resulted in reduced infiltrating neutrophils and thus perivascular
inflammation [20].
In summary, the current data demonstrates that in-utero smoke exposure modulates host
inflammatory responses to RSV infection. Our results indicate that RSV infection in SHS
exposed neonatal mice leads to increased production of CXCL1 in the airspaces and also
increases the expression of CXCR2 on neutrophils. This causes CXCL1 to bind CXCR2 on these
neutrophils and infiltrate them to lungs after RSV infection. Thus, increased influx of neutrophils
leads to exacerbated lung pathology. These findings are summarized in a proposed model shown
in Figure 6.6.
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Figure 6.6. Simplified illustration of the effect of in-utero cigarette smoke exposure on RSV
induced lung inflammation in neonatal mice. RSV infection in second hand smoke (SHS)
exposed neonatal mice induces CXCL1 production and also up regulates CXCR2 expression on
neutrophils. CXCL1 binds to its receptor CXCR2 and increased neutrophil infiltration to the site
of infection (lungs), leading to exacerbated pulmonary inflammation.
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CHAPTER 7
SUMMARY AND CONCLUDING REMARKS
7.1 Introduction
The experimental studies presented in this dissertation used two experimental mouse
models of human pneumovirus infection to delineate the role of neutrophil in host immunity. We
particularly looked at the role of these cells during human metapneumovirus (HMPV) and
respiratory syncytial virus (RSV) infections, both belonging to the pneumovirus family and
known to be the leading causes of lower respiratory tract infections in infants, elderly and
immunosuppressed individuals worldwide. Chapter 1 provides an introduction on the immune
responses induced by HMPV in the mouse model used in this dissertation (published in the peer
reviewed journal- Pathogens). Chapter 2 describes the role of neutrophils in an experimental
mouse model of HMPV infection (published in the peer reviewed journal- Journal of Leukocyte
Biology). Chapter 3 describes the role played by γδ T cells in HMPV infection (manuscript under
preparation). Chapter 4 and 5 emphasize on the role of viral attachment protein G in contributing
to neutrophil recruitment to the airways during HMPV infection [both chapters have been
published in peer reviewed journals: chapter 4 (published in the peer reviewed journal-Viruses),
chapter 5 (published in the peer reviewed journal-Future Virology as an invited editorial)].
Chapter 6 explores the effect of neutrophils in the exacerbated pulmonary inflammation
generated by in-utero smoke exposure followed by RSV infection (manuscript to be submitted).
Summarized below are the results of each chapter and discussion of their implications in
understanding the immune responses to the two clinically important respiratory pneumovirus
infections.
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7.2 Summary of results
In chapter 2, we demonstrated the role of neutrophils in HMPV infection using an
experimental mouse model of infection. This was achieved by effective depletion of neutrophils
in vivo using a monoclonal antibody, which binds specifically to and depletes neutrophils but not
any other cell population. Neutrophil depleted mice infected with HMPV had increased disease
severity (as indicated by enhanced body weight loss and high clinical score) and lung
inflammation (as demonstrated by high lung pathology score) compared to neutrophil competent
mice infected with HMPV. In further understanding the inflammation induced by lack of
neutrophils, we observed increased production of IL-17 and CXCL1 in the airways and also
increased number of γδ T cells infiltrating the lung. This observation led us to suspect that γδ T
cells might be playing a role in inducing lung inflammation in the absence of neutrophils. To
confirm this effect, we used a knock-out mouse model which lack the δ chain of the γδ TCR and
infected them with HMPV. Compared to wild-type, δTCR KO mice had significantly reduced
lung inflammation at day 7 after HMPV infection (time point when HMPV induced lung
inflammation peaks in a mouse model of infection). These results confirm two things: a) that
neutrophils regulate lung inflammatory responses by suppressing γδ T cell recruitment to the
lungs meaning neutrophils have a beneficial role during HMPV infection and b) γδ T cells during
HMPV infection induce exacerbated lung inflammation as indicated by increased lung
pathology. I further looked into the role of γδ T cells during HMPV infection in chapter 3, as
nothing has been characterized with these cells so far in HMPV induced host responses. In this
work, I observed that γδ T cells during HMPV infection regulate IL-6 production, and also
regulate neutrophil recruitment to the airways. However, γδ T cells were not involved in lung
viral clearance after HMPV infection.
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Chapters 4 and 5 describe the contribution of HMPV attachment protein (G) in neutrophil
recruitment to the airways of infected mice. Previous studies from our lab and other groups
reported the role of HMPV-G protein in regulating interferon responses in the lung [1, 2].
Furthermore, several studies have demonstrated that interferon has a suppressive effect on
neutrophil infiltration to the sites of insult [3, 4, 5, 6, 7]. Based on these two observations, we
investigated whether HMPV-G protein regulates neutrophil recruitment to the lungs after HMPV
infection. We observed that infection of mice with rHMPV-ΔG (mutant virus which lacks the G
protein) led to increased IFN-α production and decreased neutrophil influx into the airways
compared to mice infected with rHMPV (recombinant full-length virus). However, this effect
was only specific to neutrophil influx, as we did not see any change in lymphocyte or monocyte
populations after infection with rHMPV-ΔG. Also, with increased IFN-α in rHMPV-ΔG mice,
we also observed a decrease in several cytokines in the lung, which are known to have a
chemotactic effect on neutrophils. These results confirm that HMPV-G protein regulates
neutrophil recruitment to the airways after HMPV infection potentially through increased
interferon responses.
For chapter 6, we analyzed the findings described in chapter 2, where we confirm a
protective and beneficial role of neutrophils during HMPV infection, wherein they regulate the
infiltration of γδ T cells into the lungs, which induce pathology. However, neutrophils are
considered "double-edged sword". In fact, several studies in different infectious disease models
have confirmed that excess recruitment of these cells can also play a detrimental role in
enhancing inflammation [8, 9, 10]. RSV infection in infants is associated with neutrophil induced
bronchiolitis and studies have linked cigarette smoke to enhanced recruitment of neutrophils
causing aggravated lung inflammation [11, 12, 13, 14, 15]. So, we explored the aspect of
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neutrophil induced lung inflammation in in-utero smoke exposed (termed secondhand smoke
exposed) neonatal mice infected with RSV. In order to explore this aspect, we used an in-utero
cigarette smoke exposed mouse model of RSV infection. We observed that SHS exposed
neonatal mice infected with RSV had increased lung inflammation (as indicated by lung
pathology score) compared to unexposed neonatal mice infected with RSV. In further
understanding the mechanism behind this increased lung inflammation, we observed increased
production of CXCL1 in the lung, a potential neutrophil chemo-attractant. In accordance with
this observation, SHS exposed neonatal mice infected with RSV had high influx of neutrophils
into the airways compared to unexposed neonatal mice infected with RSV. Also, the neutrophils
from SHS or SHS+RSV neonatal mice were highly activated as indicated by increased CXCR2
expression (a receptor for CXCL1). Altogether, data from this chapter indicate that SHS
exposure and subsequent RSV infection induce exacerbated lung inflammation, which is
mediated by neutrophils infiltrating the airways. Therefore, excess recruitment of neutrophils can
play a detrimental role leading to exacerbated lung inflammation.
7.3 Conclusions and future direction
The data presented in this dissertation work has solid contributions in understanding the
role of neutrophils in human respiratory viral infections, as their role has remained controversial
due to the contradicting findings published so far. Based on the experimental evidences
presented here, that neutrophils in host responses can be both beneficial as well as detrimental
(Summarized in Figure 7.1 below). Thus, a fine balance in the recruitment of these cells is
necessary to impart favorable clinical outcome.
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Future studies are aimed at further understanding the mechanisms leading to neutrophil
recruitment to the sites of infection, wherein blocking those cells lead to balanced infiltration and
thus by less tissue damage. Also, exploring the mechanisms leading to the infiltration of γδ T
cells in the absence of neutrophils during HMPV infection and the pathogenesis induced by
them. Future research branching out from this work will greatly contribute to our understanding
of the innate inflammatory response to viral infections and potentially help the design of
effective therapeutic strategies for human respiratory pneumovirus infections and other
respiratory infections that induce a robust response of neutrophils.
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Figure 7.1. Summarized illustration on the role of neutrophils in respiratory pneumovirus
infection. Neutrophils during HMPV infection regulate the recruitment of γδ T cell infiltration
that in turn induce pathogenic responses in the lungs. Thus, neutrophils during HMPV infection
play a beneficial role. However, RSV infection in neonatal mice exposed to cigarette smoke inutero leads to exacerbated lung inflammation correlating with excessive recruitment of
neutrophils. Therefore, neutrophils during RSV infection in neonatal mice in an exacerbated
model of inflammation (in-utero cigarette smoke exposure) lead to exacerbated lung
inflammation demonstrating a detrimental role of neutrophils. Based on these findings, we
demonstrate that neutrophils can be both beneficial or detrimental during respiratory
pneumovirus infections, therefore a fine balance in the recruitment of these cells is critical for a
favorable outcome.
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